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ABSTRACT
The pathogenesis of equine herpesvirus type 1 (EHV-1) and 
type 2 (EHV-2) respiratory infection was studied in cell and 
organ cultures by infectivity assays following experimental 
infections (growth kinetics), and by light, scanning and 
transmission electron microscopy. The cell cultures included 
fetal donkey and pony alveolar macrophages (FDAM/FPAM), fetal 
equine kidney (FEK), rabbit kidney (LLC-RK^), and african green 
monkey kidney (VERO) cells. Organ cultures were derived from 
respiratory tissues (nasal, tracheal and pharyngeal mucosae) of 
seronegative donkey (FlDl) and pony (F1M1) fetuses, and of a 
seropositive adult pony (Al).
In the cell cultures, EHV-1 multiplied and produced 
cytopathic effects (CPE) as early as 6 hours post inoculation 
(HPI) in LLC-RK^ cells characterized mainly by cell rounding 
and lysis. EHV-2 multiplied more slowly and produced CPE as 
early as 48 HPI in LLC-RK^ FDAM, and FEK cells. The CPE 
caused by EHV-2 in the various cultures consisted principally 
of rounding of cells and syncytia formation. In EHV-2 infected 
FPAM, the appearance of CPE was preceeded by changes in 
organization of microfilaments and microtubules.
In the organ cultures morphogenesis of EHV-2 was observed 
in the nucleus of infected F1M1 nasal epithelial cells. All 
the cultures supported the growth of EHV-1 and EHV-2 except 
F1M1 pharyngeal and Al nasal cultures which were non permissive
x
for EHV-2. EHV-1 and EHV-2 were recovered from infected FlDl 
cultures for 10 and 30 days, respectively.
Cytopathic alterations produced by EHV-1 and EHV-2 were 
observed in the epithelial layer of organ cultures and were 
characterized by cessation of ciliary activity, rounding and 
shedding of ciliated and non ciliated cells. Epithelial damage 
was most extensive in EHV-1 infected cultures.
GENERAL INTRODUCTION
Three main groups of herpesviruses affect horses and these 
have been called equine herpesvirus type 1 (EHV-1), type 2 
(EHV-2), and type 3 (EHV-3). The equine herpesviruses (EHVs) are 
of both economic and research interest. Infection of horses by 
EHV-1 strains, for example, results in heavy economic losses to 
the equine industry in the form of abortions and birth of weak and 
moribund foals. For research purposes, the EHVs may provide a 
model system for studying the varying clinical and biological 
consequences of herpesvirus infections in man. The various 
clinical signs of EHV infections in horses appear similar in many 
instances to those of Herpes simplex and cytomegalovirus 
infections in man. The signs in both cases may vary from 
subclinical infection to localized lesions on the genitalia to 
severe generalized disease.
EHV-1 and EHV-3 have received much attention mainly because 
of their association with overt clinical disease. In contrast, 
only little is known about the pathogenicity of EHV-2 in horses.
In the last decade, EHV-2 has been isolated from cases of 
pharyngitis in young and old horses. Also losses due to EHV-2 
respiratory infection have been recorded among foals. Despite 
increasing reports of association of EHV-2 with equine disease, 
the pathogenesis of EHV-2 infections remains to be determined. 
Information about the pathogenic mechanisms of EHV-2 is
1
2fundamental to understanding of the nature and control of EHV-2 
disease.
This study Investigates the pathogenic potential of EHV-2 in 
equine respiratory disease by using equine respiratory organ 
cultures and a variety of cell cultures.
Since the completion of this work the designation for type 1 
equine herpesvirus involved in equine respiratory tract infections 
has been changed. EHV-1, strain KyD, (reported and used in the 
study) is currently designated EHV-4. The designation EHV-2 for 
slowly growing or slowly cytopathic equine herpesvirus (also used 
in the study) remains unchanged.
LITERATURE REVIEW
The Equine Herpesviruses (EHVs)
SIGNIFICANCE OF THE EHVs
Three antigenically distinct types of herpesviruses are known
to naturally infect the horse and other members of the equine
family and have been designated equine herpesvirus type 1 (EHV-1),
also referred to as equine abortion or rhinopneumonltis virus),
type 2 (EHV-2, also called slowly cytopathic or equine
cytomegalovirus), and type 3 (EHV-3, or equine coital exanthema 
1 2virus). * The EHVs are of considerable economic and research
Interest. Economic losses caused by EHV-1 infection are
substantial because of abortion and also respiratory disease of
3 4weanlings, yearlings, and race horses. ’ In regard to the
3general field of comparative pathology and medicine, EHVs have 
been used as a model system for studying the varied biological 
consequences of herpesvirus infections.
GENERAL PROPERTIES OF THE EHVs 
Virion morphology
The structure of equine and other herpesviruses has been 
d e s c r i b e d . ^ .8.9,10  ^eqUine viruses are similar in
structure to each other and to herpesviruses of other species.
They possess an internal DNA-containing core enclosed within an 
icosahedral capsid to form a nucleocapsid; this structure is 
surrounded by a loose outer envelope which is derived from the 
modified cellular nuclear membrane. The diameter of the enveloped 
virion ranges from 150 to 170nm. The nucleocapsid is approxi­
mately lOOnm in diameter and consists of 162 morphological 
subunits called capsomeres. The capsomeres, about lOnm across and 
15nm in length, project outwards and are radially displaced from 
one another. Intercapsomeric fibrils 2nm in diameter have been
reported to link adjacent capsomeres.
13Roizman et al described 6 features of herpesvirus structure
in electron micrographs of thin sections of infected cells. They
are: 1) a core 25-30nm in diameter, 2) an inner capsid 8-10nm
thick, 3) a middle capsid 15nm thick, 4) an outer capsid 12.5nm
thick, 5) an inner envelope lOnm thick and 6) an outer envelope
approximately 20nm thick. Spikelike projections 8-10nm in length
14are spaced 5nm apart on the envelope surface. The spikes may 
play a role in virus attachment. Many species of nucleocapsids
have been reported in herpesvirus-infected cells.^ Three of 
these were observed in various cells infected with the 
EHVs.^’^ ’^  They are: 1) empty capsids, 2) capsids with an 
electron-lucent, cross-shaped core, and 3) capsids with an 
electron dense core representing mature nucleocapsids.
Virus multiplication
Virus multiplication among the EHVs occurs in the nucleus
where their maturing nucleocapsids may give rise to
paracrystalline arrays.^ The relationship of the viral
crystalloid clusters to inclusion body formation has been
established.^ The early events of EHV-1 infection have been
studied. Virus attachment is rapid and temperature independent,
and is readily inhibited by heparin and sulfated agar
polysaccharides.^’^  Both intact and deenveloped EHV-1 enter
cells by a viropexis mechanism in which particles are engulfed by
pseudopodia which either surround the virus and fuse with the cell
membrane or fuse to other pseudopodia, forming fusion vacuoles
18containing from one to numerous viral particles.
In fetal equine kidney (FEK) cells EHV-1 was reported to have 
an eclipse period of 6 hours, and maximum level of cell-associated 
virus was attained by 20 to 24 hours while maximum level of 
extracellular EHV-1 was reached about 2 hours later.* In the same 
article, the author observed that EHV-2 had an eclipse period of 
18 hours in FEK cells and that maximal levels of cell-associated 
virus were attained after 96 hours. The growth pattern of EHV-3 
is similar to that of EHV-1. Under one-step growth conditions, an
520eclipse period of 8 hours was reported for EHV-3. In the same 
report peak EHV-3 titers were reached in 22-24 hours.
Recently Wharton et al^ found that EHV-2 had eclipse 
periods of 24 to 48 hours in LLC-RK^ (a continuous rabbit kidney 
cell line) and KyED (a fetal equine diploid cell strain) cells 
respectively. Maximum virus titers were reached at 96-120 hours 
post-inoculation. The authors noted that approximately 50% of 
total infectious EHV-2 remained cell-associated in infected KyED 
cells, while 20-40% of the infectious virus remained cell-associ­
ated in LLC-RKj cells. The authors observed 2 independent 
processes of envelopment. In the first, core-containing capsids 
interacted with the nuclear membrane and budded outward to obtain 
an envelope. In the second process, convolutions of nuclear 
membrane appeared to invaginate into the nuclear space and react 
with the capsid.
Two mechanisms have been proposed for the release of 
herpesviruses from infected cells. One involves the virus
travelling in a continuous route from the perinuclear space via
21 22 23the endoplasmic reticulum to the extracellular space. ’ *
Alternatively, the virus may travel in a discontinuous manner in
vacuoles and be secreted in a manner analogous to other exported 
24cellular products. Regardless of which mechanism actually 
prevails, enveloped virus appears to be protected from direct 
contact with the cytoplasm which might contain enzymes or factors 
that may be detrimental to the virus. Intracytoplasmic budding 
has also been reported for herpesviruses.*^
6Genetic and Antigenic Relatedness of the EHVs
Nucleic acid hybridization and restriction endonuclease
fingerprinting are two methods that have been used in studying the
genetic relatedness among viruses. In the former method, DNA or
RNA of one virus is hybridized to excess DNA of another, either
free in solution or fixed to filters. Through DNA-DNA
hybridization, 47-48% homology was noted between the DNA of herpes
25simplex virus (HSV) type 1 and type 2, suggesting a relatively
high degree of relatedness. In contrast only 17% homology between
26respiratory (R) and abortigenic (F) strains of EHV-1, and 1.0
to 8.9% between the EHVs were detected.^ The presence of
homologous sequences among viruses could indicate a common
ancestral origin or the exchange of genetic information by
recombinational events.
Recently, the R and F strains of EHV-1 were analyzed by the
26restriction endonuclease fingerprinting technique. The overall 
pattern of R strains were similar but entirely different from the 
F strains. Data from this study together with the hybridization 
results suggest that the R and F strains of EHV-1 may represent 
entirely distinct stable species.
27In serological studies, Plummer found no cross neu­
tralization among EHV-1, EHV-2 and HSV-1. However, there was 
cross reactivity between EHV-1 and EHV-2 in the complement 
fixation test. The above observations suggest that EHV-2 and 
EHV-1 may share certain group specific but not type specific 
antigens. EHV-1 shares common complement-fixing antigenic
728determinants with infectious bovine rhinotracheitis virus as 
well as with HSV-1,^
Antigenic subtypes have been reported for the EHVs. American 
and Japanese EHV-1 strains had identical complement- fixing
antigens but by serum neutralization two subtypes were
29 30demonstrable. Shimuzu et al provided evidence for the
presence of at least 2 subtypes of EHV-1. Subtype 1 was
represented by the American Kentucky-D (Ky-D) strain, and subtype
312 by the Japanese H-45 virus. In a related report Mayr et al 
noted that subtype 2 strains, including German, Swiss, Polish and 
American (Army 183), were more common in Europe than subtype 1
(Ky-D). Antigenic heterogeneity has also been reported for EHV-2
1 32 33 14strains * * but only few isolates have been studied. Past
studies on biological properties of EHV-2 have shown that with
increasing cell passage the virus becomes progressively more
cell-associated as reflected by more difficulty in isolation,
slower expression of cytopathology and a lower peak titer of
released virus.* The greater cell- association is accompanied by
altered antigenicity as measured by neutralization tests.* On the
basis of the above observations, the possibility of antigenic
drift in EHV-2 was suggested*' but remains unconfirmed.
EQUINE HERPESVIRUS .1 (EHV-1, EQUINE RHINOPNEUMONITIS VIRUS, EQUINE 
ABORTION VIRUS, EQUINE "INFLUENZA" VIRUS).
History, Distribution and Incidence:
The first report of equine herpesvirus 1 was by Dimock and 
Edwards^’^  in 1932 and 1933 in Kentucky, USA. The authors de­
8scribed abortion storms among mares in which no bacteria could be 
isolated but which could be transmitted by inoculation of mares 
with bacteriologically sterile suspensions of aborted fetuses.
The observations of Dimock and Edwards were confirmed first in
36 38 39 40Europe and subsequently in other parts of the world. *
The early investigators of equine virus abortion focused
their attention on lesions found in aborted fetuses as they were
unaware of the respiratory disease caused by EHV-1. At that
time, horses that showed signs of respiratory tract infection were
regarded as having contracted equine "influenza" even though true
39equine influenza viruses were not isolated until 1958. This
confusion in terminology makes for problems in literature
searching and logical presentations. In the following I will use
"influenza" to refer to isolates prior to 1958 of probable EHV-1
41identity. In 1941, Manninger and Csontos inoculated mares with 
a virus that they had recovered from an aborted fetus and produced 
an influenza-like disease. This led the two investigators to 
conclude that abortion was a secondary manifestation of equine
42"influenza" infection in pregnant mares. In the same year Kress
reported an outbreak of virus abortion in Austria. He observed
respiratory signs in eight horses after the abortions had occurred
and also found lung lesions in aborted fetuses. From these
findings Kress correctly concluded that the abortion virus was
pneumotropic. It is interesting to note however that in
43cross-protection trials, Doll and Kintner demonstrated an 
immunogenic relationship between the equine "influenza" and 
abortion viruses. In their experiment, inoculation of two
9seronegative young horses with the Kentucky B strain of abortion
virus resulted in refractivity to subsequent inoculation with the
Army 183 and Grayson 1 strains of equine "influenza" virus.
Antigenic similarity between equine "influenza" and abortion
viruses was also established in the study, as indicated by
reciprocal fixation of complement with antisera and antigens for
the two viruses.
The first experimental clinical observations of the
respiratory phase'of equine virus abortion were reported by Doll 
44et al in 1953. Weanling horses inoculated intravenously or
intranasally with the Kentucky-B strain of equine abortion virus
developed a febrile disease accompanied by leukopenia and symptoms
of mild respiratory infection.
It is now established that EHV-1 infection of horses may
result in any of 4 clinical syndromes including respiratory
disease, abortion, perinatal disease, and myeloencephalitis
(discussed further in the next section). Additional recent
investigations using techniques of molecular epidemiology indicate
that two distinct species of EHVs may be involved in the
respiratory and abortion syndromes, and EHV-4 has been a
26suggested name for the respiratory forms.
The early descriptions of disease caused by EHV-1 called it
epizootic equine abortion or virus abortion of mares. To
provide a more specific descriptive name and to differentiate it
46from the "influenza" and viral arteritis virus, Doll et al 
suggested the use of the name equine rhinopneumonitis for the 
disease and equine rhinopneumonitis virus for the etiological
10
agent. Subsequently, Plummer  ^proposed the name equine 
herpesvirus 1 for equine rhinopneumonitis virus to differentiate 
it from equine herpesvirus 2, the LK virus.
Clinical Signs
In a recent review, 4 clinical syndromes were associated with
47exposure of horses to EHV-1. They are: respiratory disease,
abortion, myeloencephalitis, and perinatal disease. The
respiratory syndrome which is thought to have an incubation period
of 2-10 days occurs mainly in foals, weanlings, and yearlings, and
is characterized by fever, anorexia and serous to mucopurulent
nasal discharge. In uncomplicated cases recovery is usually
48spontaneous in 5-7 days. However, secondary bacterial invasion 
may occur and the affected animals may develop bronchopneumonia. 
Mild or subclinical respiratory disease is commonly seen in horses 
with antibodies to EHV-1. EHV-1 infection of the pregnant mare 
may lead to fetal infection and subsequent abortion. After 
experimental exposure to the virus, seropositive pregnant mares 
abort in 14-120 days without premonitory signs of disease. 
Following natural exposure most mares abort at 6-11 months of 
gestation although fetuses of all ages are susceptible. Infected 
mares may occasionally also show nervous signs (myeloencephalitis 
syndrome) or they may give birth to weak foals (perinatal syn­
drome) . The presenting signs in such foals may include respi­
ratory distress, watery, non-fetid diarrhea, and weakness during 
the first few weeks of life. The foals survive until two weeks of 
age when signs of secondary bacterial infections become apparent.
11
Pathology
47
Campbell and Studdert gave a detailed account of the
pathology of the 4 syndromes of EHV-1 disease. EHV-1 respiratory
disease is rarely fatal. Deaths, if they occur are due to
overwhelming secondary bacterial infections. Necrotic lesions may
be present in the respiratory epithelium and lymphoid germinal
centers. In addition, intranuclear inclusion bodies may be
observed in the affected tissues. In the abortion syndrome, the
natural route of infection is presumed to be via the upper
respiratory tract, followed by a cell- associated viremia,
resulting in placental transfer and infection of the fetus with
47subsequent abortion. Many workers have described the various
lesions in aborted fetuses. Gross pathological changes consist of
hydrothorax, numerous subcapsular necrotic areas in the liver, and
45hemorrhages in the visceral organs. Histologically, necrotic
lesions are found in the lung, liver, and spleen in addition to
7 49widespread hemorrhages and edema. Dimock observed eosinophilic
intranuclear inclusion bodies at the periphery of necrotic lesions
in the liver and lung of aborted fetuses. However, these
inclusion bodies may disappear following inflammation or
post-mortem autolysis.^ The most consistent lesion observed in
the mare after abortion is an intense perivascular infiltration of
lymphocytes and plasma cells around blood vessels located just
47beneath the glandular layer of the endometrium. Prior to 
abortion, intravillar necrosis accompanies perivascular cuffing 
resulting in complete separation of the allanto-chorion and 
uterine endometrium. ^
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In the perinatal disease syndrome, gross lesions are confined
to the respiratory tract and are characterized by edema and
enlargement of the lungs and bronchial lymph nodes and hemorrhages
in the trachea and bronchi. Microscopic lesions consist of
nonsuppurative inflammatory changes throughout the lower
respiratory tract, eosinophilic intranuclear inclusion bodies
especially in the lungs, and depletion and/or degeneration of
lymphocytes in lymphoid tissues. In the myeloencephalitis
syndrome, vasculitis appears to be the prominent lesion with
secondary hypoxic degeneration in adjacent neural tissue. The
frequent failure to isolate virus from nervous tissue in this
syndrome is probably a consequence of virus-antibody complexes,
formed either in vivo or in vitro during the preparation of
47tissues for inoculation of cell cultures.
Diagnosis
Diagnosis of EHV-1 disease in the past was based on history, 
clinical signs and pathological findings.^’"^ Recent methods for 
diagnosis of EHV-1 abortions and respiratory tract infections 
include virus isolation, serology, histopathology, electron
microscopy, and immunofluorescence microscopy of infected
„ . . 40,48material.
Epidemiology
Available literature indicates that horses are the natural
hosts of EHV-1 with a high prevalence of viral antibodies of
51 52 5385-92% in some areas. * Doll and Bryans observed that the
virus may be spread by direct (ingestion or inhalation) or
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indirect contact. They observed that mares which aborted late in
pregnancy had been in contact with foals with EHV-1 respiratory
47signs. Alternatively, Campbell and Studdert noted that
epizootic abortion was initiated by abortion in a recently
introduced pregnant mare. Further, these authors deduced that the
aborted fetus, membranes, and fluids may be an important source of
infection for mares and that abortion occurs because the strain of
virus is appropriate and the immunity of the mare has diminished
to an extent that allows local virus multiplication with
subsequent viremia and transplacental transfer. Doll and 
53Bryans have suggested that a natural reservoir or a high
incidence of carriers may exist among adult horses. The possible
role of donkeys as carriers of EHV-1 has not been investigated,
however, previous work by Henning"^ has revealed that donkeys may
be more resistant to EHV-1 infection than horses.
In recent years the epidemiology of EHV-1 infection has
become more complex with the identification of many strains of
54EHV-1. Burrows and Goodridge observed that differences in 
virulence occur between those strains of virus which cause 
respiratory disease and those associated with abortion outbreaks. 
Their in vitro studies indicated that the abortigenic strains had 
a wider tissue culture host range than the respiratory strains.
In addition to classification as abortigenic or respiratory 
strains, type 1 EHVs have also been characterized as subtype I (if 
they were antigenically closely similar to Kentucky D, the 
prototype abortigenic strain) and subtype 2 (if they differed
14
40slightly but consistently from subtype 1 viruses). The source
of virus, whether from an aborted fetus or from the respiratory
tract of a horse, did not necessarily determine the subtype.
40However, majority of isolates from fetuses were subtype 1.
Currently, restriction enzyme analysis has been suggested to be
the best available method for distinguishing EHV-1 strains.
Through this technique differentiation has been successfully made
26between respiratory(R) and abortigenic(F) strains of EHV-1, as
55well as between plaque variants of EHV-3.
Mechanism of persistence of EHV-1
Whether EHV-1 survives in the convalescent animal as a
chronic or latent infection is not clear. Latent herpesvirus
infections with periodic recrudescences following a variety of
natural and artificial stimuli are recognized in man and some 
47animals. Seroepidemiological studies indicate that 70-100% of 
people over 15 years of age have been exposed to herpes simplex 
virus l(HSV-l) but only approximately half of these suffer from 
clinical disease with the other half shedding or not shedding 
virus in the absence of symptoms.
Latent infectious bovine rhinotracheitis virus infection was 
activated in cattle by the administration of corticosteroids but
similar experiments involving EHV-1 in the horse proved to be
57 58 59inconclusive. ’ In 1978, Burrows and Goodridge provided
indirect evidence for EHV-1 latency by recovering the virus from
the nasal secretions of ponies in an isolated herd. Neutralizing
antibody (4-fold increase and above) was demonstrated in seven of
eight ponies involved in the study.
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A number of possible mechanisms of herpesvirus latency have
been postulated.^ In both DNA and RNA viruses, a latent infection
may be established by the integration of the viral genome into
that of the host. The balance between virus infectivity and
interferon stimulating activity could also contribute to the
development of a latent infection. Thus, an increase in virus
titer may stimulate infected cells to produce interferon, which in
turn inhibits the multiplication of the virus. This removes the
stimulus for further production of interferon, and the subsequent
decline of interferon concentration results in multiplication of
the virus. This again stimulates the cells to produce interferon,
and the cycle continues. Evidence is accumulating that defective
interfering (DI) particles or mutant viruses could contribute to
the persistence of viral infections in animals and man.^^ Among
the EHVs, EHV-1 has been shown to produce DI particles both in
61 63vivo and in vitro. ’ However, the recovery of defective or 
mutant viruses in latently infected animals does not establish 
their role in the initial infection and, to date, the evidence for 
persistent or latent infections with EHV-1 remains circumstantial. 
Immunity
The immunity resulting from EHV-1 infection is of short 
duration. Many horses experience a number of infections during
r j  c O
their lifetime. Studies by Doll and Bryans showed that horses
could become reinfected within 3 to 5 months. Such reinfection
64was observed by Burrows and Goodridge to be subclinical and was 
thought to be related to the presence of neutralizing antibodies.
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64Burrows and Goodridge showed that ponies with serum neutralizing 
antibody titers of greater than 1:24 were resistant to 
experimental infection by intranasal exposure to EHV-1. However, 
relatively high serum antibody titers have been observed in some 
vaccinated mares that aborted.^
There is no clear understanding of the role of immune 
mechanisms in either protection from disease or the pathogenesis 
of disease for a herpesvirus of any species.^ Nevertheless, it 
has been stated in general that cell mediated immune (CMI) 
responses play a central role in the prevention of and recovery 
from herpesvirus disease. ^  The results of studies by Gerber et 
al^ are in agreement with the general statement above. In their 
vaccination studies with modified live EHV-1 vaccine, the authors 
found that 6-8 month old horses showed only slight or no increase 
in anti EHV-1 serum neutralizing antibody. However, these same 
horses showed a marked increase in the CMI response to EHV-1 as 
measured by the lymphocyte transformation test. In the same study 
lymphocytes from pregnant mares showed a decreased sensitivity to 
EHV-1 after exposure to virulent EHV-1 while lymphocytes from non 
pregnant mares and stallions showed an increase in the 
incorporation of tritiated thymidine following stimulation by 
EHV-1. The observed EHV-l-induced depression of CMI response late 
in gestation may account for the increased susceptibility of mares 
to EHV-1 infection and the subsequent temporally associated 
abortions. It is believed that cytotoxic antibodies or cells 
could also participate in restricting virus spread after 
infection. ^  Finally, because herpesvirus-infected cells induce
surface cell membrane changes, antibody can bind to these 
virus-coded surface antigens and cooperate with various effector 
cells (eg macrophages and polymorphonuclear leucoytes) in 
antibody-dependent cell-mediated cytotoxicity (ADCC)."^
Two commercially available EHV-1 vaccines (fetal origin) 
have been d e s c r i b e d , a R^Hed virus vaccine preparation 
(Pneumabort-K, Fort Dodge Laboratories, Iowa) and the attenuated 
live virus vaccine (Rhinomune, Norden Laboratories, Lincoln, 
Nebraska). Only the inactivated vaccine is licensed for the 
prevention of abortion in mares. It is also recommended for the 
prevention of EHV-1 respiratory disease in young animals. The 
attenuated vaccine is currently licensed only for the prevention 
of the EHV-1 respiratory syndrome but it is also being used on 
some farms for immunoprophylaxis against EHV-1 abortions in mares. 
Live vaccines have to be used with great circumspection as a 
possibility always exists for reversion of vaccine virus to 
virulence. Subunit vaccines containing EHV-1 envelope components 
(glycoprotein fraction) have been observed to protect hamsters 
against EHV-1 challenge.^ The potential for the use of this 
vaccine in horses as an alternative to the conventional vaccines 
is yet to be clearly determined.
Experimental Host Systems
Although members of the family Equidae have been reported as 
being the natural hosts of EHV-1, the virus also has a wide 
experimental host range with regard to both animal and tissue 
culture systems. Abortions following EHV-1 infection have been
18
recorded in guinea pigs.^’"^ EHV-1 has been adapted to suckling
hamsters,^ and has been grown also in fertile eggs.^
The biological properties of EHV-1 were studied in detail
with the advent of tissue culture methods. The cultivation of
EHV-1 was first made in 1953 in Maitland type tissue culture
72systems with tissues of horses. Subsequently the virus was
cultivated in monolayer cultures of various animal tissues.
73Studies of Kock indicate that in primary monolayer cultures of
horse kidney, the Army 183 strain of EHV-1 multiplies to peak 
7 8titers of 10 to 10 TOID^/ml whereas the Ky-D strain attains
peak titers of 10"’*^ "’ to 10^*® TCID^Q/ml in the same culture
system. Bagust^ listed 17 primary and 14 continuous cell line
74cultures which are susceptible to EHV-1. Bartha made some 
observations on the growth and cytopathic expression in tissue 
culture adapted and field (native) strains of EHV-1. Tissue 
culture adapted strains multiplied more rapidly than primary 
isolates producing extensive degeneration of cultures in 24 to 48 
hours versus 3 to 5 days for CPE with field isolates.
The use of organ cultures for the study of virus/cell 
interactions is now well established. O'Niell and Issel^ 
studied the kinetics of EHV-1 release from fetal equine 
respiratory organ cultures. Initial peak titers were observed 
from tracheal cultures (24 hours) but beyond 24 hours virus was 
released to higher titers from nasal cultures. In studies 
involving EHV-1 growth in organ cultures of foal trachea, Burrows 
and Goodridge found that EHV-1 strains recovered from the
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respiratory tract were less virulent than those recovered from the 
fetus. Fetal strains grew more rapidly than the respiratory 
strains and reached a ten-fold higher peak concentration of virus 
over a 5-day growth period. The authors remarked that monolayer 
cultures are not particularly useful for basic studies of cellular 
and tissue specificity or the growth of viruses in vivo. They 
suggested that a better estimate of the growth of virus in the 
normal host may be obtained in organ cultures and that the slower 
growth of EHV-1 respiratory strains compared to that of the fetal 
strains in organ cultures of foal trachea could be a reflection of 
decreased virulence for the horse.
EQUINE HERPESVIRUS 2 (EHV-2, SLOWLY GROWING OR SLOWLY CYTOPATHIC 
EHV, EQUINE CYTOMEGALOVIRUSES)
History, Incidence and Clinical Significance
In 1963 in England, Plummer** reported the isolation of a 
herpesvirus from a horse suffering from catarrh. He found the 
virus to be serologically distinct from the classic equine 
abortion or rhinopneumonitis virus and proposed that the abortion 
virus be called equine herpesvirus 1, and his isolate, also called 
the LK virus, equine herpesvirus 2. Since then equine herpesvirus
2 (EHV-2) strains have reportedly been isolated in many countries
76 77including Japan in 1964, Switzerland in 1966, Germany in
7ft 7Q ftn
1967, South Africa in 1966, United States in 1968, Australia
in 1970,^ and Hungary in 1978.^
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The prevalence of EHV-2 based on serology is very high among
83horse populations and may reach 90% in some cases. Infection of
84horses with EHV-2 is reported to occur before 4 months of age.
85Wilks and Studdert detected EHV-2 neutralizing antibody in the
serum of 7 mares but not in presuckling serum of their progeny.
Furthermore, they did not isolate EHV-2 from nasal swabs nor from
buffy coat samples obtained from any of the foals at the time of
birth, although the virus was present in the buffy coat cells of 1
mare at parturition. Thus horses may become infected with EHV-2
postnatally rather than prenatally, and at present no evidence
exists for transplacental transfer of EHV-2.
EHV-2 has been associated with some forms of respiratory
disease and the virus is frequently recovered from tissues such
as kidney, spleen, testicle and buffy coat cells where its
significance is unknown.* Some workers recovered EHV-2 from the
nasal cavity of 3 horses for 418 days after experimental 
86infection. This observation is in marked contrast to the
failure to isolate EHV-1 and EHV-3 for longer than 14 days after
primary infection.* In another study, EHV-2 antibody in foals
85after natural infection persisted for 180 days. These 
observations support the statement that once infected a horse 
appears to be a life long carrier and a seemingly constant shedder 
of EHV-2.* The apparent ubiquitous nature of EHV-2 makes it 
difficult to determine its significance.
Nomenclature
On account of the comparatively long eclipse period, the time 
taken to attain peak titers, and a marked tendency for the virus
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to remain cell-associated, the name "slowly cytopathic" or "slowly
growing" was suggested for EHV-2.* In addition to the above
characteristics some "slowly cytopathic" equine herpesviruses that
were unrelated by cross-neutralization to the LK strain of EHV-2
were observed to exhibit a restricted host range in vitro and
they also produced dense basophilic intranuclear inclusion bodies
as well as occasional basophilic intracytoplasmic inclusion
bodies. For these reasons the name "equine cytomegalovirus" was
32proposed for these viruses.
Some investigators have questioned the classification of
EHV-2 isolates as members of a distinct cytomegalovirus-subgroup
87of the herpesviruses. Thus Plummer et al concluded: "The
present criteria for regarding a virus as a cytomegalovirus are
exceedingly vague. Until criteria which are a little more
definitive become available, we suggest that new herpesviruses not
be refe'rred to as cytomegaloviruses even it they do grow slowly in
tissue cultures." During in vivo and in vitro studies of 6
88strains of EHV-2, Harden et al failed to find any evidence of 
intranuclear inclusion bodies in the salivary glands of 30 horses 
even though EHV-2 strains were isolated from 7 of them. Also the 
viruses were shown to have a wide host range in vitro and no 
intracytoplasmic inclusions were observed in infected cells. 
Furthermore, congenital infection of foals could not be produced 
with the strains of EHV-2, and virus could not be isolated from 
the urine of the 30 horses. These results indicated that the 
EHV-2 strains involved in the study did not share features
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commonly associated with herpesviruses classified as cytomegalo­
viruses. The investigators therefore suggested that the type 2 
equine herpesviruses not be classified as cytomegaloviruses.
EHV-2 and Equine Disease
The significance of EHV-2 in the pathogenesis of equine 
disease is not clear due to the frequent isolation of the virus 
from both sick and apparently healthy horses. However, evidence 
has accumulated in recent years pointing to an etiological 
relationship between EHV-2 infection and disease.
Initial infection with EHV-2 is believed to occur by
inhalation.^ The virus has been recovered from horses that showed
obvious signs of respiratory disease.*' These included marked
enlargement of the regional lymph nodes and a profuse mucopurulent
nasal discharge resulting probably from secondary bacterial
complication. In another report the virus was isolated from 12
foals and 2 adults of Arabian and other breeds with mild clinical
89 90respiratory tract infection. Thein has recovered EHV-2 from 
conjunctival swabs taken from adult horses and 4-week old suckling 
foals with keratoconjunctivitis manifested as photophobia,
excessive lacrimation, and blepharospasm accompanied by pannus.
91Blakeslee et al provided some evidence associating EHV-2 
with respiratory tract infection of horses. In their study two 
6-week old foals (designated as horse 1 and horse 3 respectively), 
and 3 adult horses were infected intranasally with 3x10^ TCID^ of 
EHV-2, strain LK. The 6-week old foals with relatively low levels
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of virus neutralizing and complement-fixing antibodies developed 
coughs and serous nasal discharges within 21 days. Laryngoscopic 
examination revealed pharyngitis manifested as edema and hyperemia 
of the dorsopharyngeal recess with lymphoid proliferation in the 
pharyngeal walls. The pharyngitis persisted for 232 days in one 
foal (horse 1) and 98 days in the other (horse 3) with virus 
recovered for 118 days in horse 1 and 98 days in horse 3. None of 
the three seropositive adult horses exhibited clinical signs of 
disease although virus was recovered for 4 and 35 days in two of 
the adults.
Results of the study above seem to indicate that EHV-2 is 
capable of establishing an infection in horses and that young 
foals may be more susceptible to infection than adults. They also 
support the concept of EHV-2 causing a persistent infection in 
horses, as indicated by continued isolation of virus in the
presence of circulating antibodies.
82In 1978 Palfi et al in Hungary reported on a series of 
respiratory disease outbreaks in which losses due to EHV-2 were 
recorded in 6 to 10 week old foals. The outbreaks, which 
prevailed for several months, had a morbidity of nearly 100% and a 
mortality that ranged from 5% to 40% among the foals. EHV-2 could 
be isolated from the nasal discharge of acutely ill animals in 
every case. Over 4-fold increases inneutralizing antibody could be 
demonstrated against EHV-2 in acute and convalescent sera in all 
cases. However, no rise in antibody titer could be demonstrated 
against EHV-1, equine influenza or A^, parainfluenza-3, or
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against the soluble antigen of the first subgroup of bovine 
adenoviruses.
The pathological features of the disease included catarrhal 
pneumonia, lung abscess, and interstitial pneumonia with evidence 
of secondary bacterial infection. During one of the outbreaks, 
Corynebacterium equi could be cultivated from lung lesions and 
from the regional lymph nodes. On the basis of the absence of 
EHV-2 neutralizing antibody in the sera of acutely ill animals and' 
the subsequent appearance of high titer antibody in their 
convalescent sera, it was suggested that EHV-2 was the primary 
causal agent of respiratory disease of the affected foals. There 
was correlation of the clinical illness with loss of detectable 
colostral antibody against EHV-2.
Despite reports of the pathogenic potential of EHV-2, the 
pathogenesis of infection of horses with the virus remains to be 
clearly defined. Three factors may account for this observation:
1) little documentation of the pathogenic significance of EHV-2 is 
available; 2) the lack of in vitro models for studying EHV-2 
infections; and 3) the lack of animals unexposed to the virus, 
thus making it difficult to do controlled or field trials with the 
agent.
Experimental Host Systems
In an investigation of the characteristics of various strains 
of EHV-1 and EHV-2 (including EHV-2 strain LK), Erasmus"^ 
inoculated the viruses intraperitoneally in newborn hamsters, and 
intracerebrally in day-old mice. He also applied the viruses to
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the scarified skin and cornea of rabbits. Except for the EHV-1 
strain, which produced fatal hepatitis in newborn hamsters, no 
indication of infection was observed in any of the host systems 
inoculated with the viruses. In the same study, no pocks or other 
signs of infection were observed in 10-day-old embryonated eggs 
after infection with the viruses. However, all the virus strains 
produced CPE in primary and secondary cultures of fetal horse 
kidney, lamb kidney and rabbit kidney cells, after varying periods 
of incubation. The CPE induced by EHV-1 appeared as early as 16 
hours post infection (HPI) and was characterized by ballooning of 
cells and their rapid detachment from the glass substrate. The 
CPE progressed very rapidly to complete cell destruction at 24 
HPI. With the EHV-2 strains, development of CPE was slow and the 
time of appearance of CPE varied from 24 to 96 hours depending on 
the cell type used. For example, for EHV-2 LK strain grown in 
fetal horse kidney, the time of appearance of CPE fell in the 
range of 48 to 96 hours, and in rabbit kidney cells, the same 
virus induced CPE formation in 24 to 72 hours. In addition, 
formation of large syncytia frequently occurred with the EHV-2 LK 
strain, and Vero cells were found to be highly susceptible to the 
virus. It is interesting to note that while some EHV-2 strains 
showed a high degree of cell association in fetal horse kidney 
cells, the EHV-2 LK strain exhibited the least amount of cell 
association. More information is available on cell types from
various animal species that will support the growth of EHV-2
„ . 2,88 strains.
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88About a decade ago, Harden et al suggested that the use of 
organ cultures among other techniques may help to elucidate 
details of the pathogenesis and spread of EHV-2 infections. To 
date no studies have been undertaken in connection with light, 
scanning and transmission electron microscopic examination of 
EHV-2-infected organ cultures of equine respiratory (nasal, 
pharyngeal and tracheal) epithelium.
Respiratory Tract Defense Mechanisms
The Mucociliary Clearance Mechanism
The patency and integrity of respiratory airways is
maintained by means of mucus secretion and its transport by
ciliary activity. The mucociliary clearance system was recently 
92reviewed. Ciliated cells are distributed in patches in various 
regions of the respiratory tract. Intervening areas are composed 
of goblet cells and undifferentiated columnar cells. It was 
observed that under normal conditions mucus was sparse and 
discontinuous in the nasal, tracheal and bronchial airways. The 
cranial direction of ciliary beat and constant ciliary motility 
were included in the criteria for normal ciliary activity.
As the mucus traps inhaled particles and ciliary movements 
occur, the particles (eg. viruses and bacteria) are transported to 
the pharyngeal region where they are swallowed. Primary 
malfunction of cilia has been emphasized as an important 
pathogenetic step in the production of serious respiratory
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92disease. A reduction in the movement of mucus either by 
depression of ciliary activity or by an increase in mucus 
secretion is likely to allow more time for virus to penetrate the 
respiratory mucosa. Virus particles that pass beyond the 
mucociliary system to the alveoli may encounter alveolar 
macrophages and may be phagocytosed.
Role of Macrophages
Macrophages are an important component of host defense
against virus infections. They participate in many activities
including phagocytosis and killing of viruses, production of
interferon, destruction of virus-infected cells, and the
93development of immune responses. Virus infection of macrophages
may result in death of the macrophages or may lead to a persistent
infection of the macrophages which may then aid in the spread of
the virus. •
Role of Secretory IgA
IgA is the chief immunoglobulin secreted on mucosal surfaces.
it exists in several different forms but that present in
secretions is composed of two four-chain units plus a separate
glycoprotein, termed secretory piece, synthesized not by
94lymphocytes but by epithelial cells. IgA produced by B
lymphocytes underlying the mucosal epithelium is selectively
transported across the epithelial cells into the mucus layer.
Antibodies of the IgA class predominate in nasal secretions and
they may neutralize a virus and prevent its attachment to 
95epithelial cells.
I
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The Role of Interferon
The interferon system was reviewed recently.^ Many 
interferons are soluble glycoproteins produced by stimulated cells 
which, when released, are capable of protecting other cells 
against virus infection. Interferon appears earlier than humoral 
and cell mediated immune responses and it is operative within 
hours of infection.
Interferon does not directly inactivate virus. Instead, it 
acts by reacting with membranes of cells surrounding the producer 
cells to derepress genes which code for antiviral effector 
molecules that inhibit viral protein synthesis. Viral protein 
synthesis may be inhibited by changes affecting initiation of 
protein synthesis, polypeptide elongation, and function of viral 
mRNA. These changes may be mediated directly or indirectly by 
interferon effects on induction of protein kinases, depletion of 
specific tRNAs, activation of an endonuclease, methylation changes 
in viral RNA, and a general alteration of cellular RNAs.
The role of interferon in recovery from viral infectons 
depends mainly upon two factors, namely, the effectiveness of the 
virus as a stimulator of interferon production, and the 
susceptibility of the virus to the antiviral action of interferon. 
Most respiratory tract viruses are believed to be highly sensitive 
to interferon.
29
Effect of Virus on Cytoskeletal Elements
Three chemically distinct filamentous systems constitute the
cytoskeleton of vertebrate cells: microfilaments, intermediate
97filaments, and microtubules. The filaments of each system have 
characteristic diameters: microfilaments (5-7nm), microtubules
go
(20-25nm), and intermediate or lOnm filaments (8-12nm). The
interactions of these systems with one another appear to be
essential for several cellular functions including maintenance of
cell shape, intracellular transport, motility, and adhesion.
Microfilaments are structures found in nonmuscle cells that
perform many functions related to cell motility. They are also
involved in the three-dimensional organization of the
99cytoskeleton. The term microfilament is now reserved for
actin-containing filaments with a diameter of about 7nm.
Recently, a microfilament-associated protein, called fimbrin, was
demonstrated to crosslink filamentous actin (F-actin) in vitro to
99form bundles of filaments. The possibility of involvement of
this phenomenon in polymerization and depolymerization of
transient structures known to contain fimbrin, such as membrane 
ruffles and microvilli, was considered.
The intermediate-sized filaments are the least understood of 
the three filamentous systems. They form an interconnecting
network and provide what appears to be a cytoskeletal frame-
. 101 work.
Microtubules are the collective name given to subcellular 
components whose basic subunit is tubulin.Microtubules are
i30
ubiquitous in eukaryotic cells where they may be involved in such
102diverse functions as changes in cell shape, cell surface
receptor mobility,secretion of hormones,and mitosis.
Microtubules are present in centrioles, and they have also been
found in motile cellular appendages such as cilia and
flagella.*^’* ^ Biochemical studies indicate that colchicine,
vinblastine, and related drugs interfere with microtubule
polymerization due to their ability to bind the tubulin 
109subunit. These drugs have been used to demonstrate the 
involvement of microtubules in the cellular activities mentioned 
above.
Pathological changes in many viral diseases are reflected in 
morphological alterations of cells. An investigation of the 
mechanisms by which viruses cause cytopathic effects associated 
with cell morphology changes will provide insight into the 
pathogenesis of viral diseases.
One method for studying cytoskeletal changes in cells is the 
microtubule paracrystal (PC) assay. The basis for the microtubule 
PC assay is that treatment of cultured cells with vinblastine 
sulfate results in the formation of large microtubule paracrystals 
which are easily detected under the phase contrast 
microscope. The technique was used by Ebina et al*^ to
investigate the role of microtubules in cytopathic changes induced 
by animal viruses. Data from the investigation indicated that the 
appearance of CPE in adeno-and herpesvirus-infected HeLa cells was 
correlated with a molecular alteration of microtubules detectable
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by the inhibition of PC formation. Another method is the indirect 
immunofluorescence technique which has been used extensively to 
detect morphological alterations of cytoskeletal
components.^*98, a<jvant;ages of the immunofluores­
cence method was discussed in relation to cytoplasmic microtubules
113in normal and transformed cells in culture. The procedure is
simple, and it permits immediate resolution of microtubules in
cultured mammalian cells. The images produced by the technique
correlate closely with transmission electron microscopic images of
cytoplasmic microtubules. Immunofluorescence studies have shown
that canine distemper virus causes a total reorganization of all
the cytoskeletal structures with the most notable changes in the
114microtubules and intermediate filaments.
In the work that follows, the biological and pathogenic 
properties of EHV-2 were assessed in various experimental host 
systems including cell cultures (equine and continuous cell 
lines), and equine respiratory organ cultures (fetal and adult origin). 
EHV-1 provided a comparative model for EHV-2 infections in the 
study. The following investigations were made: 1) virus growth
in cell and organ cultures, 2) effect of virus infection on 
ciliary activity of organ cultures and on cell monolayers, 3) 
virus morphogenesis in organ cultures, 4) effect of virus 
infection on surface morphology of organ cultures, and 5) effect 
of virus infection on the cytoskeleton.
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CHAPTER 1
EQUINE HERPESVIRUSES TYPE 1 AND 2: GROWTH AND
CYTOPATHIC EXPRESSION IN CELL AND ORGAN CULTURES
48
SUMMARY
The pathogenicity of equine herpesvirus type 1 (EHV-1) and 
type 2 (EHV-2) were assessed and compared in monolayer cultures 
of equine and continuous cell lines and in equine respiratory 
organ cultures. The equine cell lines included fetal donkey 
alveolar macrophages(FDAM) and fetal equine (pony) kidney 
(FEK), and the continuous cell lines included rabbit kidney 
(LLC-RK^) and african green monkey kidney (VERO). Organ 
cultures were derived from respiratory tissues (nasal, tracheal 
and pharyngeal mucosae) of seronegative donkey (F1D1) and pony 
(F1M1) fetuses,and of a seropositive adult pony (Al). 
Pathogenicity of EHV-1 and EHV-2 was demonstrated in the cell 
and organ cultures, and EHV-1 was observed to be more 
pathogenic than EHV-2.
In cell cultures, EHV-1 multiplied and produced cytopathic 
effects (CPE) as early as 6 hours post inoculation (HPI) in 
LLC-RK^ cells. The CPE induced by EHV-I was characterized 
mainly by cell rounding and lysis. EHV-2 multiplied more 
slowly and produced CPE as early as 48 HPI in LLC-RK^, FDAM, 
and FEK cells which consisted mainly of rounding of cells and 
syncytia formation.
In organ cultures, EHV-1 multiplied more rapidly and to 
higher peak titers than EHV-2. Growth of EHV-2 was inhibited 
in Al nasal cultures but not in the F1M1 and F1D1 nasal cul­
tures in which infectious virus was recovered for at least 14
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days in F1M1 cultures, and at least 30 days in F1D1 cultures. 
Multiplication of EHV-2 was restricted in pharyngeal cultures. *
Infectious EHV-2 could not be detected in pharyngeal culture 
fluids after 5 days post inoculation (DPI). Ciliary activity 
in tracheal and nasal cultures terminated earlier in EHV-1 and 
EHV-2 infected cultures than in uninfected cultures. The time 
interval from attainment of peak virus titer to cessation of 
ciliary activity ranged from 0 (simultaneous occurrence) to 6 
days for EHV-1 and 3 to 27 days for EHV-2. The in vivo 
significance of the results is discussed.
INTRODUCTION
Equine herpesvirus type 1 (EHV-1) and type 2 (EHV-2) have
been implicated in acute respiratory tract disease in horses
1-3during their first two years of life. In addition, EHV-1
may cause abortion and nervous syndromes in pregnant mares.
Serologic data indicate that both viruses are widespread among 
2 6horse populations. ’ The pathogenesis of equine herpesvirus
(EHV) induced respiratory disease is poorly understood. One
reason for our poor understanding is that most horses have been
naturally exposed and only few seronegative horses are
available for experimental studies.
Organ and cell cultures have been used for the study of
7-9virus-cell interactions. Infection patterns in organ
cultures especially may mimic those in whole animals, as
demonstrated in the replication of infectious bovine
rhinotracheitis virus in different bovine tissues,^ and
11 12influenza virus in different ferret tissues. * The combined 
use of organ and cell culture techniques may help to elucidate 
details of the pathogenic mechanisms operative in equine 
herpesvirus respiratory infections.
The purpose of the present study was to investigate the 
pathogenicity of EHV-1 and EHV-2 in vitro using a variety of 
cell lines and organ cultures derived from equine respiratory 
tissues.
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MATERIALS AND METHODS
Virus
EHV-1(strain KyD) and EHV-2 (strain LK) were obtained from 
Dr. J.E. Pearson, National Animal Disease Center, Ames, Iowa. 
Stock suspensions of EHV-1 and EHV-2 were prepared by 1 and 2 
passages in monolayer cultures of either rabbit kidney 
(LLC-RK^) in the 257th to 258th subpassages, or fetal equine 
kidney (FEK) in the 2nd to 4th subpassages. The viral prepa­
rations were stored at less than -60 C until used.
Cell cultures
Rabbit kidney epithelial cell line LLC-RK^(ATCC it 
CCL106/S921, passage 253) and the the VERO line of african 
green monkey kidney cells (ATCC it CCL81/S1415, passage 251) 
were obtained from the Cell Culture Center at the School of 
Veterinary Medicine, Louisiana State University, Baton Rouge. 
Primary cell cultures of fetal equine kidney (FEK) were 
prepared by standard methods, using a growth medium consisting 
of Eagle's minimal essential medium (MEM) supplemented with 10% 
fetal bovine serum (FBS), 100 IU of potassium penicillin G and 
100 meg of streptomycin sulfate/ml. The medium was buffered to 
a final concentration of lOmM NaHCO^ and 25mM HEPES 
(N-2-hydroxyethyl piperazine-N-2-ethanesulfonic acid). The FEK 
cells were used in the 2nd to 7th subpassages.
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Donkey alveolar macrophage (FDAM) cultures were initiated
from a near-term donkey fetus. The fetus (F1D1) was delivered
by Caesarean section and was immediately exsanguinated after
collection of blood (by jugular venipuncture) for serology.
Blood was also collected from the dam (Dl) for a similar
purpose. The lungs with a piece of trachea (approximately 3
inches in length) attached were removed and aseptically
transported to a vertical laminar flow hood (Nuaire, Inc,
Plymouth, Mn.) where bronchopulmonary lavage was performed.
The constituents of the lavage fluid were as described 
13previously with minor modifications. The fluid contained 
0.15M saline, 5mM glucose, 2mM EDTA, 25mM HEPES 
buffer, pH 7.2, 5 meg of amphotericin B per ml, 200 IU of 
potassium penicillin G per ml, and 200 meg of streptomycin 
sulfate per ml. The trachea was clamped close to its point of 
bifurcation, and using a 50 ml syringe and 18 gauge needle, 
lavage fluid was introduced into the lungs which were then 
gently massaged. The fluid was then collected by suction into 
a 50ml syringe. Washing of the lungs required a total of 100ml 
of lavage fluid and about one-half of this could be recovered. 
The washings were centrifuged at 300g for 10 minutes in a 
Beckman centrifuge (Beckman, Spinco division, Palo Alto, 
California). The pellets were resuspended and pooled in a 
growth medium (described above). The cells were counted in a 
hemocytometer chamber and the suspension was diluted to give 
0.5 to 1.0 x 10^ cells/well. The suspension was added to 6-well 
cluster plates (Flow Laboratories, Inc., Hamden, Connecticut)
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so that there were about 0.5 to 1.0 x 10^ cells/well.
The cultures were incubated for 3 h at 37C in a humidified
atmosphere containing 5% CX^. At this time, they were washed
twice with MEM to remove nonadherent cells, and reincubated. In
14 to 25 days, dense isolated colonies appeared in the cultures
which could readily be subcultured, using standard procedures,
to form monolayers of epithelial type cells. The cells were
judged to be alveolar macrophages on the basis of the presence
of esterases as demonstrated by staining with alpha-naphthyl 
14acetate. Their plastic adherence properties and morphology 
as determined by phase-contrast examination (cytoplasmic 
spreading, accumulation of refractile vacuoles and vesicles, 
and short cytoplasmic extensions with enlarged blunt ends) and 
their subsequent survival in culture for over 60 days (without 
subculturing) were additional evidence.^ The alveolar 
macrophages were used in the 7th subpassage.
Organ Cultures
Relevant portions of the respiratory tract were obtained
from near-term donkey (F1D1) and pony (F1M1) fetuses and from a
6-year old apparently healthy adult pony (Al). Serum was
harvested from jugular blood of these donors and tested in
neutralization tests. Nasal and tracheal organ cultures were
prepared according to methods previously described by O'Niell 
16and Issel. Two nasal fragments, each approximately 0.7 cm x 
0.7 cm, were planted with their epithelial surfaces up in each 
60 mm plastic tissue culture dish (Falcon Labware Division, 
Oxnard, California). Tracheal rings were placed in 60 mm
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plastic tissue culture dishes, one or two rings per dish, 
depending on size. For the pharyngeal cultures, mucosal 
sections (approximately 1.5 xl.5 cm) were removed aseptically 
from the pharynx of a pony fetus. The sections were rinsed 3 
times in MEM supplemented with 200 IU of potassium penicillin G 
per ml, 200 meg of streptomycin sulfate per ml, 5 meg of 
amphotericin B per ml, and planted, 2 per dish, in 60 mm 
plastic tissue culture dishes.
Organ cultures in each dish were maintained in 3 ml of 
Leibovitz's L-15 medium (Gibco, Grand Island NY) at 37 C in a 
humidified chamber. Tracheal and pharyngeal cultures were 
rotated at 100 rpm on a gyrorotary platform (Labline 
Instruments, Inc., Melrose Park, 111). Viability of the nasal 
and tracheal cultures was assessed by observing ciliary 
motility with an inverted microscope. After 24 or 48 
hours, cultures with immotile cilia were discarded and the rest 
were used for virus growth studies.
Virus titration
Infectivity titrations were performed in FEK cell
monolayers in microtiter plates. Ten-fold dilutions of virus
were made in MEM containing antibiotics, and 0.025 ml of each
dilution was placed in replicate wells of 96-well microtiter
plates (Costar, Cambridge, MA). Control wells received 0.025ml
2
of MEM. FEK cell monolayers in 75-cm (surface area) flasks 
were trypsinized using versene (EDTA) trypsin (0.8% NaCl, 0.04% 
KCL, 0.1% dextrose, 0.058% NaHC03> 0.02% EDTA, and 0.25% 
trypsin) and resuspended in growth medium to a concentration of
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1.0 x 10^ cells/ml. To each well of the microtiter plates 
0.05ml of the cell suspension was added and the plates were 
incubated at 37 C for 6 days. The plates were examined daily 
with an inverted microscope and scored on the basis of viral 
cytopathic effects (CPE). The 50% endpoint was determined by 
the Reed-Muench method.^
Neutralization Test
A microneutralization test was performed on serum samples
18collected from donor animals as described. Serum was heat 
inactivated (56 C for 30 min) and stored at -20 C until used in 
the serum neutralization (SN) test. The SN test was performed 
in FEK cells in 96-well microtiter plates (Costar, Cambridge, 
MA). Serum dilutions of 1:2 to 1:64 were made in two-fold 
steps, with each dilution being tested in duplicate wells.
Virus neutralizing titers were expressed as reciprocal of the 
final serum dilution that completely inhibited CPE with 100-250 
TCID^q of virus. Endpoints were determined 7 days after 
inoculation.
Virus growth in cell cultures
Monolayers of FEK(12 x 10^ cells), FDAM (2 x 10^ cells) 
VERO (12 x 106 cells) and LLC-RK1 (8 x 106 cells) in 25cm2 
flasks, (Costar, Cambridge, MA) were inoculated with EHV-1 and 
EHV-2 at a multiplicity of infection (MOI) of 10, except for 
VERO cells which were inoculated with EHV-1 at MOI of 6.6. At 
various intervals, culture fluids were harvested and stored at 
less than -60 C until titrated for extracellular virus.
Cultures were also examined daily for CPE which were scored as
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follows: 0= Normal cell morphology was observed, +_ = Less than 
25% of the monolayer exhibited CPE, + = 25% to 50% of the 
monolayer exhibited CPE, ++ = 50% to 75% of the monolayer 
exhibited CPE, +++ = 75% to 95% of the monolayer exhibited CPE 
++++ = over 95% of the monolayer exhibited CPE.
Virus growth in organ cultures
Prior to virus inoculation, organ cultures were maintained 
for 24 to 48 hours after initiation. Medium was removed from 
culture dishes and cultures were inoculated by dropping 0.5 ml 
of virus suspension on the epithelial surface of the principal 
tissue fragments; inocula of approximately 8 x 10^ TCID^q of 
EHV-1 or approximately 4 x 10^ TCID^q of EHV-2 were added to 
each dish. Virus was allowed to adsorb for 1 h after which 
time infected cultures were washed 3 times in phosphate 
buffered saline (PBS). This was followed by the addition of 3 
ml per dish of Leibovitz's L-15 medium. The medium was changed 
daily after harvesting aliquots for titration from infected and 
uninfected cultures. Samples were stored at less than -60 C 
until used. Growth kinetic studies were made on pools of 
medium obtained from groups of 3 or 4 dishes.
Ciliary activity of infected and uninfected nasal and 
tracheal organ cultures was monitored daily using an inverted 
microscope. Ciliary activity was scored on an all or none 
basis, i.e., if any ciliary movement was noted it was recorded 
as positive.
RESULTS
Virus growth in cell cultures (i) Growth Kinetics.
To determine loss of infectivity experienced during the 
period of incubation used for the cell and organ cultures, 
aliquots of stock virus in medium with 10% FBS were incubated 
at 37C for 4 to 8 days. At daily intervals, samples were 
removed, frozen and stored at less than -60C until infectivity 
titrations were made in FEK cell monolayers in microtiter 
plates. After 24 hours of incubation at 37C, loss of 
infectivity equivalent to 75% for EHV-1 and 84% for EHV-2 was 
observed (Table 1). By 4 days, 97% of infectivity of both 
EHV-1 and EHV-2 was lost, and by 8 days, only 0.8% of original 
infectivity of EHV-2 remained.
Growth of EHV-1 and EHV-2 occurred in FEK, FDAM, VERO, and 
LLC-RK^ cells, with EHV-1 multiplying to a peak titer earlier 
but attaining a lower peak titer than EHV-2 in all the cell 
cultures (Tables 2 and 3).
(ii) Cytopathic effects.
In EHV-1 infected cultures (Table 2), CPE were observed as 
early as 6 hours post inoculation (HPI) in LLC-RK^ monolayers, 
and at 24 HPI over 95% of the monolayer was involved. Cells in 
the monolayer became rounded and swollen. At 96 HPI the 
degenerate and fragile cell sheet detached from the flask. CPE 
were evident at 12 HPI in FEK and FDAM cultures and progressed 
faster in FEK than in FDAM cells. At 24 HPI, CPE in FEK cells 
were characterized by vacuolation and lysis of cells. By 72 
HPI over 90% of the cells forming the monolayer had
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degenerated. In EHV-1 infected FDAM cultures, CPE at 24 HPI 
consisted of few rounded, refractile cells. By 48 HPI many 
rounded and vacuolated refractile cells were present in the 
monolayer. CPE in EHV-1 infected VERO cultures were delayed 
until 48 HPI (Table 2). Between 48 and 96 HPI, CPE progressed 
from ++ to ++++ and refractile rounded cells predominated.
In EHV-2 infected cultures (Table 3), CPE appeared as 
early as 48 HPI in FEK, FDAM, and LLC-RK^ cells, and as late as 
72 HPI in VERO cells, and consisted of cell rounding, breaks in 
continuity of monolayers, and syncytia formation.
Immune status determination
Serum samples from the fetuses were negative for 
neutralizing antibodies to EHV-1 and/or EHV-2, whereas those 
from their dams were antibody-positive for the two viruses 
(Table 4).
Virus growth in organ cultures
Growth kinetics of EHV-I and EHV-2 in equine respiratory 
organ cultures are presented (Tables 5-9). Virus growth 
occurred in all cultures except F1M1 pharyngeal (Table 8) and 
A1 nasal (Table 9) cultures. Infectious virus was recovered up 
to 10 (EHV-1) and 30(EHV-2) days post inoculation (DPI) from 
infected F1D1 cultures (Tables 5 and 7). In F1D1 cultures 
EHV-1 multiplied to a 10-fold higher peak titer than EHV-2 
(Figs 1 and 2) but titers of EHV-1 declined steadily after 
reaching,peak values while thoseof EHV-2 reflected a steady 
state infection (Figs 3 and 4).
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Ciliary activity of uninfected (control) and virus 
infected equine respiratory organ cultures are shown (Tables 
10-14). The time interval from attainment of peak virus titer 
to cessation of ciliary activity ranged from 0 (simultaneous 
occurrence) to 6 days for EHV-1, and 3 to 27 days for EHV-2. 
Ciliary activity of all tissue sections ceased as early as 2 
DPI (EHV-1 infected A1 nasal, Table 11), 6 DPI (EHV-2 infected 
F1D1 tracheal, Table 12), 10 DPI (control F1D1 tracheal, Table
12), and as late as 8 DPI (EHV-1 infected F1D1 nasal, Table 
10), 31 DPI (EHV-2 infected F1D1 nasal, Table 12), over 38 DPI 
(control F1D1 nasal, not shown). In A1 cultures, ciliary 
movements stopped at about the same time in EHV-2 infected 
nasal and tracheal cultures (7 and 8 DPI, respectively, Table
13). In general, ciliary movements were abolished earlier in 
cultures infected with EHV-1, as indicated by data from F1D1 
studies (Table 14).
DISCUSSION
Results of the present study indicate that EHV-1 and EHV-2 
are potentially pathogenic as determined by their ability to 
grow and cause CPE in monolayer cultures of equine alveolar 
macrophages as well as cause earlier cessation of ciliary 
activity in infected than in uninfected equine respiratory 
organ cultures. EHV-1 grew more rapidly and was more 
cytopathic than EHV-2.
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The CPE caused by EHV-1 occurred early and were
characterized by cell rounding and lysis, whereas EHV-2 CPE
developed late and they consisted of rounding of cells and
syncytia formation. Similar findings have been described by 
19Erasmus. Our present findings support the concept of EHV-2 
having a prolonged growth cycle and delayed CPE in cultured 
cells.20
Alveolar macrophages supported the growth of EHV-1 and
EHV-2. Peak virus titers in FDAM were relatively low when
13compared with those in FEK cells. Forman et al also observed
this difference in virus yields in relation to the replication
of IBR virus in cultured bovine alveolar macrophages (AM) and
Madin-Darby bovine kidney (MDBK) cells. Relatively low yields
of infectious IBR virus was attained in AM as compared with
high yields in MDBK cells. Since cell cultures in the above
studies were inoculated at an input multiplicity of infection
of 10, it is possible that the low yields in the macrophage
cultures were due to the production of low quantities of
infectious virus on a per-cell basis.
Even though EHV-1 and EHV-2 attained lower titers in FDAM
than in FEK cells, CPE became manifest at the same time in the
two cell types suggesting that CPE may develop without release
of large numbers of infectious virus. The replication of EHV-1
and EHV-2 in cultured FDAM with subsequent production of CPE
may have significant implications in the pathogenesis of equine
respiratory disease as the alveolar macrophage functions as the
21primary defense against inhaled particulate matter. Virus
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infection of the lung may impair the microbicidal function of
alveolar macrophages as well as expose bacterium-specific
receptors on- lung tissue. These processes may promote
bacterial adherence to pulmonary tissue and lead eventually to
3
severe bacterial pneumonia. Thus Palfi et al isolated
Corynebacterium equi from the lungs of foals that died from
22EHV-2 respiratory illness. Studdert has also reported 
involvement of streptococci of Lancefield's Group C in acute 
EHV-1 respiratory disease.
In infected LLC-RK^ cells, sharp decreases in EHV-1 titer 
correlated well with rapid production of CPE in contrast to the 
small decreases in EHV-1 titer in thermal decay studies. This 
difference reflects the detachment of virus infected cells and 
their subsequent loss during the washings and media 
replenishment.
Although biological properties such as virus growth and 
CPE may be studied in cell cultures, it may be noted that 
infection patterns in dedifferentiated cells may not represent 
the situation in vivo. Therefore in pathogenicity studies, it 
may prove more useful to couple short-term cell culture studies 
with organ culture or whole animal studies.
Equine nasal and tracheal organ cultures supported the 
growth of EHV-1 and EHV-2 except that EHV-2 growth was 
inhibited in nasal cultures derived from a seropositive adult 
pony. Probably the high levels of serum neutralizing antibody 
to EHV-2 (titer 1:64 or over) in the donor pony was associated 
with high titers of residual anti-EHV-2 IgA that may have
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neutralized EHV-2 and prevented its multiplication in the nasal 
cultures. In contrast, low levels of anti-EHV-1 neutralizing 
antibody (titer 1:4) reflected in low titers of residual 
anti-EHV-1 IgA could have allowed EHV-1 to multiply in the 
nasal cultures. By comparison, EHV-1 grew more rapidly in the 
organ cultures during the first 24 to 48 hours and reached much 
higher peak titers than EHV-2.
It is noteworthy that in the cell culture studies peak
titers of EHV-1 were lower than those of EHV-2. Also, EHV-1
and EHV-2 were released to higher peak concentrations in cell
cultures than in organ cultures, suggesting that infections in
cell cultures may differ from those in organ cultures which
consist of fully differentiated cells that may vary widely in
their susceptibility to a virus. Although immune and
inflammatory responses may be largely absent in organ cultures,
previous work indicates that infection patterns in these
cultures closely approximate in the vivo situation.^ ^
23Blakeslee et al cited from Harden and co-workers that 
pharyngeal lymphoid follicles might be the initial site of 
EHV-2 replication with subsequent transmission to other 
organs via mononuclear cells (probably monocytes) of the blood. 
On the basis of this assumption, our present findings in 
pharyngeal cultures are somewhat unexpected as EHV-2 titers 
were much lower when compared with the high titers in nasal 
cultures. In addition, infectious EHV-2 was not detected in 
pharyngeal culture fluids after 4 DPI.
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Previous reports indicate that organ cultures from 
different anatomic regions of the respiratory tract may differ 
in their ability to support virus growth. Shroyer et al^ 
found that IBR virus was released more readily from infected 
fetal bovine tracheal epithelium than from infected nasal 
epithelium. O'Niell et al^ reported that equine influenza 
virus-A^ grew better in fetal equine nasal epithelium than in 
tracheal epithelium. In the present study, EHV-1 grew slightly 
better in fet^l and adult equine tracheal cultures than in 
nasal cultures.
Two factors may account for the above difference in
susceptibilities of nasal and tracheal tissues, namely, the
presence of virus-specific receptors on epithelial cells and
the immunologic competence of the organ concerned.
Virus-specific receptors may mediate virus attachment to cells
and thus facilitate virus multiplication. Differences in the
number of cells with virus-specific receptors in tracheal and
nasal epithelia may be responsible for the differential
susceptibilities of these tissues. It has been reported that
the number of ciliated cells in mammalian airways decreases
24toward the smaller airways. Thus different regions of the 
respiratory tract may show different susceptibilities to virus 
infection if the infection depends on the presence of ciliated 
cells.
A variation in immunologic competence is thought to exist
25for different regions of the respiratory tract. Wilkie 
reported that within the respiratory tract secretions, IgG and
IgA predominate, but the ratio of IgA to IgG varies so that IgA
predominates in the nose whereas the quantity of IgG increases
in tracheal secretions. Antibodies of the IgA and IgG classes
may neutralize virus and prevent virus infection of epithelial
cells of the respiratory tract. The relative amounts of these
immunoglobulins in local secretion at the time of virus
exposure may determine the outcome of infection. Future
experiments with respiratory organ cultures should test for the
presence of virus-specific antibodies in nasal and tracheal
secretions prior to harvesting the tissues for virus
inoculation studies. It has been reported that beyond 6 months
of gestation, the equine fetus acquires increasing ability to
22produce immune responses. The significance of these responses 
in determining the relative susceptibility of tracheal and 
nasal mucosae to virus infection may require further investiga­
tion.
26Burrows and Goodridge have observed that ponies with 
serum neutralizing (SN) antibody titer greater than 1:24 are 
resistant to experimental intranasal EHV-1 challenge. Findings 
from our studies appear to reflect this view. Nasal organ 
cultures made from tissues of a pony adult (Al) that had SN 
antibody titer of 1:4 were found to be susceptible to EHV-1 
infection.
Our present results and in vivo observations of other 
workers appear to indicate that a certain minimum level of SN 
antibody would also protect members of the equine species
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against intranasal EHV-2 challenge. Nasal organ cultures 
derived from pony (F1M1) and donkey (F1D1) fetuses each of 
which had no detectable SN antibody supported the growth of 
EHV-2 , but similar cultures derived from an adult pony (Al) 
having SN antibody titer greater than 1:64 and probably having 
residual mucosal IgA antibody were non permissive for EHV-2. 
Organ culture results, however, have to be interpreted with 
caution as important differences exist between organ cultures 
and the parent tissue in vivo. Environmental factors such as 
immune responses, microbial flora, cooler temperature of nasal 
tissue, and inhibitory substances in mucosal secretions may be 
present in vivo but absent in organ cultures. It is therefore 
possible that organ culture findings may not represent what 
actually occurs in the intact animal. Nevertheless, organ 
cultures may mimic the in vivo situation more closely than cell 
cultures.
23Blakeslee et al infected 3 adult horses and two 6 week 
old foals intranasally with 3.0 x 10^ TCID,.^  of EHV-2 strain 
LK. Prior to their experiment, SN antibody was demonstrated in 
the adults. One of the foals had low levels of SN antibody 
(titer 1:2) and the other had none detectable. Both foals 
developed a chronic pharyngitis whereas this lesion was not 
observed in the adults. Passive immunity in the foals and 
active immunity in the adults may have protected the animals 
from developing an acute respiratory tract disease. Palfi et al
3
did not detect SN antibody in 6 to 10 week old foals that had 
acute EHV-2 respiratory disease. Further investigation is
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needed in regard to the role of serum neutralizing antibody 
levels in protection of horses against EHV-2 infections. The 
significance of nasal mucosal resistance should not be totally 
excluded as the upper respiratory tract is the portal of entry 
for most respiratory viruses. The possibility of age-dependent 
resistance to infection with EHV-2 also requires investigation 
as the above observations suggest that young animals may be 
more susceptible than older ones to EHV-2 infection. Losses due 
to EHV-2 may, however, decrease among young stock having 
antibody passively derived from the dam. Finally, the 
phenomenon of viral interference (mediated probably via 
interferon production by previously infected nasal epithelial 
cells) may have contributed to failure of EHV-2 multiplication 
in Al nasal cultures, as an uncharacterized cytopathic agent 
was isolated from culture fluids of uninoculated Al nasal and 
tracheal cultures (data not shown).
Our results appear to support an in vivo observation of 
27Henning that horses may be more susceptible than donkeys to 
EHV-1. EHV-1 reached a ten-fold higher peak concentration in 
pony adult than in donkey fetal cultures. An epidemiologic 
implication of findings in these studies is that donkeys as 
members of the Family Equidae, could act as carriers for EHV-1. 
Our findings suggest that donkeys may also be less susceptible 
than ponies to EHV-2 infection as the virus multiplied to a 
ten-fold higher peak titer in pony than in donkey fetal nasal 
cultures. However, in fetal tracheal cultures, EHV-2 titers 
remained constant for at least 5 days in donkey cultures but
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showed an inconsistent pattern in pony cultures during the same 
period.
An interesting finding of this study was the consistent
isolation of EHV-2 from susceptible nasal organ cultures for at
least 31 days and at least 14 days in infected donkey and
pony fetal nasal cultures respectively. The finding agrees
with the observation of previous investigators that EHV-2
causes a persistent infection of horses. After intranasal
inoculation of two 6-week old foals with EHV-2, Blakeslee et al 
23 consistently isolated the virus for 118 days from one foal
and 98 days from the other. Other workers have recovered EHV-2
from the nasal cavity of experimentally infected horses for 418 
28days. One must assume that the EHV-2 infected horse may shed
EHV-2 for an indefinite period of time. The frequent
isolations of EHV-2 strains from buffy coat cells suggest that
EHV-2 latency may be maintained in these cells which may also
serve to spread the virus to other sites of the body such as
6 22the testicle, genital tract, spleen, and kidney. ’ These in
vivo observations are in marked contrast to the failure to
isolate EHV-1 for longer than 14 days after primary 
22infection. Further work concerning the treatment of virus 
inoculated organ cultures with specific antibody would provide 
additional information on EHV-2 persistence. Persistence of 
infection in the presence of antibody would imply intracellular 
survival and/or intercellular spread of EHV-2 both of which may 
help in counteracting host immune defenses.
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Ciliary activity in tracheal and nasal cultures terminated
earlier in infected cultures than in uninfected cultures and a
variation in the time interval from attainment of peak titer to
cessation of ciliary activity in all cultures was observed for
EHV-1 and EHV-2. For EHV-1, the interval ranged from 0 to 6
days whereas for EHV-2, the interval ranged from 3 to 27 days.
These results and the other accumulated data suggest EHV-1 to
be more pathogenic than EHV-2. The suggestion is supported by
the ability of EHV-1 strains to cause abortions and acute
respiratory disease while EHV-2 strains cause subclinical
infections and only occasional severe respiratory disease after 
1 3  22natural exposure. ’ ’ The present results suggest that 
combined use of cell and organ culture models can provide 
useful information on pathogenic mechanisms of viral infections 
of the respiratory tract.
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Table 1 - Thermal decay of EHV-2 and EHV-1 in cell-free medium* 
containing 10% fetal bovine serum at 37C____________
Titer of virus (Log^O TCID5O/O.025ml) on given 
day after incubation at 37C__________________
Virus 0 1 2 3 4 6 8
EHV-2 6.2# 5.4 5.4 4.8 4.6 4.6 4.1
EHV-1 6.3 5.7 5.5 5.2 4.7 ND ND
* Minimum essential medium (Eagle), with hepes (25mM), pencillin G 
(100 IU/tnl), and streptomycin (lOOmcg/ml).
# Virus titer prior to incubation. Virus titration was made in fetal 
equine kidney (FEK) monolayers in microtiter plates.
ND = Not determined.
Table 2 - Growth kinetics of EHV-1 in equine and continuous cell lines*
Extracellular virus titer^/CPE**on given times after inoculation
Cell type## 1.5h 6h 12h 24h 48h 72h 96h 120h
FEK 2.5/0 2.7/0 6.0/+ 6.5/+ 6.0/++++ 5.5/++++ 4.8/++++ 3.5/++++
FDAM 1.3/0 1.7/0 3.2/+ 5.0/+ 4.2/++ 4.0/+++ 3.0/++++ 2.3/++++
VERO 2.0/0 3.0/0 3.2/0 4.0/0 5.0/++ 5.3/+++ 5.0/++++ 4.7/++++
LLC-RKj 2.2/0 2.0/+ 4.7/++ 5.7/++++ 5. 0/++++ 3.0/++++ 1.8/NA 0/NA
* Cell monolayers were inoculated with virus at a multiplicity of infection (MOI) of 10 (except for 
Vero. cells which was 6.6).
# Expressed as log^o TCID50/O.025 ml; virus titration was made in FEK monolayers in 
microtiter plates.
** Rated as follows: 0 = No CPE, _+ = less than 25% of monolayer exhibited CPE, + = 25%-50% of
monolayer exhibited CPE, ++ = 50%-75% of monolayer exhibited CPE, +++ = 75%-95% of monolayer 
exhibited CPE, ++++ = >95 of monolayer exhibited CPE.
## Equine cell lines: FEK = fetal equine kidney, FDAM = fetal donkey alveolar macrophage.
Continuous cell lines: VERO = african green monkey kidney, LLC-RKj = New Zealand white rabbit 
kidney.
NA = Not applicable; all cells detached from the flask surface.
Table 3 - Growth kinetics of EHV-2 in equine and continuous cell lines*
Extracellular virus titer^/CPE**on given times after inoculation
Cell type## 6h_______ 12h______ 24h______ 48h______ 72h_______ 96h_______ 120h______ 144h
FEK 2.7/0 1.0/0 3.7/0 6.0/+ 7.0/+ 5.7/++ 4.7/++++ 4.5/++++
FDAM 1.5/0 0.7/0 3.5/0 5.0/+ 5.0/+ 5.7/++ 4.7/++++ 3.7/++++
VERO 2.7/0 0/0 2.2/0 3.5/0 4.7/+ 5.5/jf 5.5/+ 4.7/++
LLC-RKi 2.5/0 0.7/0 4.5/0 5.3/++ 6.0/++++ 5.0/++++ 4.7/NA 3.5/NA
* Cell monolayers were inoculated with virus at a multiplicity of infection (MOI) of 10.
# Expressed as log^Q TCID^q/0.025 ml; virus titration was made in FEK monolayers in microtiter 
plates.
** Rated as follows: 0 = No CPE, +_ = less than 25% of monolayer exhibited CPE, + = 25%-50% of
monolayer exhibited CPE, ++ - 5G%-75% of monolayer exhibited CPE, +++ = 75%-95% of monolayer 
exhibited CPE, ++++ = >95 of monolayer exhibited CPE.
## Equine cell lines: FEK = fetal equine kidney, FDAM = fetal donkey alveolar macrophage.
Continuous cell lines: VERO = african green monkey kidney, LLC-RK^ = New Zealand white
rabbit kidney.
NA = Not applicable; all cells detached from the flask surface.
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Table 4 - Neutralizing antibody titer to EHV-2 and EHV-1 in sera of 
experimental animals
Animal EHV-2
Titer*
EHV-1
Pony fetus (FlMl) <2 ND
Dam (Ml) 32 ND
Pony adult (Al) >_64 4
Donkey fetus (F1D1) <2 <2
Dam (Dl) 2 4
* Expressed as reciprocal of final serum dilution inhibiting viral 
cytopathic effects (CPE) with 100 or 250 TCID50 of virus. Serum 
neutralization test was performed in microtiter plates using fetal 
equine kidney (FEK) cells.
ND = Not determined.
Table 5 - Growth kinetics of EHV-1 in fetal donkey (FIDl) respiratory organ cultures
Titer of virus (Log^g TCID^g/O.025ml) in culture fluid* on given day after 
inoculation_________________________________________________________________
Organ culture______0.5_______ 1________ 2________ 3________ 4________ 5________ 6_______ 7_______ 1_0
Nasal 1.1 2.7 3.5 2.6 1.8 1.2 1.2 1.2 1.0
Tracheal 2.4 3.8 2.8 1.6 1.0 0.6 0 ND ND
* Pool from 3 culture dishes; each dish (60 x 15mm Petri dish) had received 0.5ml of a virus 
suspension containing 10^"® TCID5g/0.025ml. Virus titration was performed in fetal 
equine kidney (FEK) monolayers in microtiter plates.
ND = Not determined.
Table 6 - Growth kinetics of EHV-1 in adult pony (Al) respiratory organ cultures
Titer of virus (Log^Q TCID^q/0.025ml) in culture fluid* on given day after 
inoculation____________________________________________________________
Organ culture______0.5________ 1________ 2_________3________ 4________ 5_________ 6_________ 7_
Nasal 1.5 3.0 4.3 3.4 1.6 0.7 0.7 0
Tracheal 3.5 4.3 4.5 3.0 2.6 2.6 1.3 0
* Pool from 3 culture dishes; each dish (60 x 15mm Petri dish) had received 0.5ml of a virus 
suspension containing 106,6 TCID5 q/0.025ml. Virus titration was performed in fetal
equine kidney monolayers in microtiter plates.
Table 7 - Growth kinetics of EHV-2 in fetal donkey (FlDl) respiratory organ cultures
Titer of virus 
inoculation
(L°g io t c i d50/0.025ml) in culture fluid* on given day after
Organ culture 0.5 1 2 3 4 5 6 7 10 14 20 30
Nasal 1.5 1.5 2.4 2.4 2.7 2.5 2.3 2.0 2.4 2.5 2.0 1.7
Tracheal ND 2.0 2.5 2.5 2.5 2.5 2.5 ND ND ND ND ND
* Pool from 3 culture dishes; each dish (60 x 15mm Petri dish) had received 0.5ml of a virus 
suspension containing 106’3 TCID50/O.025ml. Virus titration was performed in fetal 
equine kidney (FEK) monolayers in microtiter plates.
ND = Not determined.
Table 8 - Growth kinetics of EHV-2 in fetal pony (FlMl) respiratory organ cultures
Titer of virus 
inoculation
(Log^Q TC1D50/o. 025ml) in culture fluid* on given day after
Organ culture 0.5 - 1 2 3 4 5 6 7 10 14
Nasal 2.7 2.6 2.8 3.0 3.9 2.6 3.7 2.8 2.8 3.7
Tracheal 3.5 2.6 2.0 1.5 1.6 0 0.7 1.4 2.2 0.8
Pharyngeal 1.8 2.0 2.2 0.9 0.6 0 0 0 0 0
* Pool from 4 culture dishes; each dish (60 x 15mm Petri dish) had received 0.5ml of a virus 
suspension containing 10^'2 TCIDjg/O.025ml. Virus titration was performed in fetal 
equine kidney (FEK) monolayers in microtiter plates.
Table 9 - Growth kinetics of EHV-2 in adult pony (Al) respiratory organ cultures
Titer of virus (LogjO TCID^q/O.025ml) in culture fluid* on given day
after inoculation____________________________________________________________
Organ culture______ 1________ 2________ 3________ 4________ 5________ 6________ 7_______ 10_______ 14
Nasal 0.7 0 0 0 0 0 0.7 0 0.6
Tracheal 2.0 0.8 1.4 1.8 1.8 1.2 0.6 0 0
* Pool from 3 culture dishes; each dish (60 x 15mm Petri dish) had received 0.5ml of a virus 
suspension containing 10^'^ TCIDjq/O.025ml. Virus titration was performed in fetal 
equine kidney (FEK) monolayers in microtiter plates.
Table 10 - Ciliary activity of EHV-1 infected fetal donkey (FIDl) respiratory organ cultures
No.
with
of cultures 
virus
with mot ile cilia on given day after inoculation
Organ culture 0* 1 2 3 4 5 6 7 8
Nasal
Infected (n = 6 sections) 6 6 6 6 6 4 3 2 0
Uninfected (n = 7 sections) 7 7 7 7 7 7 7 7 7
Tracheal
Infected (n = 6 rings) 6 6 3 3 2 0 0 0 0
Uninfected (n = 7 rings) 7 7 7 7 7 5 5 4 1
* Prior to inoculation with virus.
Table 11 - Ciliary activity of EHV-1 infected adult pony (Al) respiratory organ cultures
No. of cultures 
with virus
with motile cilia on given day after inoculation
Organ culture 0* 1 2 3 4 5 6 7 8
Nasal
Infected (n = 6 sections) 6 4 0 0 0 0 0 0 0
Uninfected (n = 6 sections) 6 4 3 2 2 2 2 2 2
Tracheal
Infected (n = 6 rings) 6 6 6 6 6 3 0 0 0
Uninfected (n = 6 rings) 6 6 6 6 6 6 6 2 1
* Prior to inoculation with virus.
Table 12 - Ciliary activity of EHV-2 infected fetal donkey (FlDl) respiratory organ cultures
No. of cultures with motile cilia on given day after inoculation 
with virus
Organ culture 0* 2 4 6 8 10 12 14 16 20 30 31
Nasal
Infected (n = 6 sections) 6 6 6 6 6 6 4 4 3 2 1 0
Uninfected (n = 7 sections) 7 7 7 7 7 7 7 7 7 7 7 7
Tracheal
Infected (n = 6 rings) 6 4 4 0 0 0 0 0 0 0 0 0
Uninfected (n = 7 rings) 7 7 7 5 1 0 0 0 0 0 0 0
* Prior to inoculation with virus.
Table 13 - Ciliary activity of EHV-2 infected adult pony (Al) respiratory organ cultures
No. of cultures 
with virus
with motile cilia on given day after inoculation
Organ culture 0* 1 2 3 4 5 6 7 8
Nasal
Infected (n = 6 sections) 6 5 4 4 3 2 1 u 0
Uninfected (n = 6 sections) 6 4 -3 2 2 2 2 2 2
Tracheal
Infected (n = 6 rings) 6 6 6 6 6 6 4 1 0
Uninfected (n = 6 rings) 6 6 6 6 6 6 6 2 1
* Prior to inoculation with virus.
Table 14 - Time of cessation (days) of ciliary activity in > 50% of uninfected and equine herpesvirus
infected respiratory organ cultures.*
Organ culture Control EHV-2
Virus
EHV-1
Nasal
Pony adult (Al) 2 4 2
Pony fetus (FlMl) >14 14 ND
Donkey Fetus (FlDlJ >3! 15 6
Tracheal
Pony adult (Al) 7 7 5
Pony fetus (FlMl) >14 >14 ND
Donkey fetus (FlDl) 8 5 3
* Organ cultures were infected with 0.5ml per culture dish of an EHV-1 suspension containing 10®*®
TCID50/0*025ml and of an EHV-2 suspension containing approximately 10®*^ TCID50/0.025 ml. 
ND = Not determined.
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EQUINE HERPESVIRUSES TYPE 1 AND,2: 
ELECTRON MICROSCOPIC 
STUDIES IN CELL AND ORGAN CULTURES
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SUMMARY
Cell cultures of equine alveolar macrophages and 
respiratory organ cultures (nasal, pharyngeal, tracheal) were 
inoculated with equine herpesvirus type 1 (EHV-1) or type 2 
(EHV-2). The two viruses and their interactions with the cell 
and organ cultures were studied by transmission and scanning 
electron microscopy.
By transmission electron microscopy capsids of EHV-1 and 
EHV-2 were found to be morphologically similar to each other 
and to those of other herpesviruses. Typical herpesvirus 
morphogenesis was seen in thin sections of EHV-2 infected nasal 
organ cultures and virus was released into intercellular 
spaces.
Scanning electron microscopy revealed that cytopathic 
changes in EHV-1 and EHV-2 infected macrophage cultures con­
sisted of rounding of cells and their retraction from the 
substrate. Spherical particles assumed to be EHV-1 and EHV-2 
virions were observed budding from the plasma membrane of 
macrophages.
Cytopathic alterations produced by EHV-1 and EHV-2 were 
observed in the epithelial layer of organ cultures. EHV-1 
induced alterations in nasal and tracheal cultures were ob­
served within 48 hours post inoculation (HPI) and were charac­
terized by rounding and lysis of epithelial cells. EHV-2
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induced surface changes were observed as early as 48 HPI in 
pharyngeal cultures and 96 HPI in nasal and tracheal cultures. 
The changes in pharyngeal cultures consisted initially of 
extensive desquamation of pharyngeal epithelial cells, and 
later of cell rounding. Infected nasal and tracheal cultures 
displayed cell rounding and loss of ciliated and non-ciliated 
cells.
INTRODUCTION
Equine herpesvirus type 1 (EHV-1) and type 2 (EHV-2) have
been associated with some acute respiratory tract infections of 
1-4horses, but little documentation of the pathogenic mecha­
nisms involved in such infections is available. Acute EHV-1 
respiratory disease in foals is characterized by fever, 
anorexia, profuse serous nasal discharge, necrosis of 
epithelial cells of the upper respiratory tract accompanied by 
an inflammatory response, and occasionally, a bronchopneumo­
nia.^ Clinical and pathologic features almost identical to 
those of EHV-1 infection have been reported for EHV-2 infection
3
in foals. Some workers have reported that a chronic
pharyngitis with follicular proliferation in pharyngeal walls
may develop in foals after EHV-2 infection.^
Several workers have utilized organ cultures in
pathogenesis investigations to study respiratory viruses
including rhinoviruses, influenza viruses, parainfluenza
6—12
viruses, togaviruses, coronaviruses and herpesviruses. 
Transmission electron microscopy (TEM) has been used to study
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ultrastructural characteristics of viruses and virus infected 
cells, and scanning electron microscopy (SEM) has been used to 
study surface topography of such systems. The purpose of the 
present report was to use TEM and SEM to observe internal and 
surface features of cell and organ cultures infected with EHV-1 
and EHV-2.
MATERIALS AND METHODS
Viruses
Reference strains of EHV-1 and EHV-2 were obtained from 
Dr. J.E. Pearson, National Animal Disease Center, Ames, Iowa. 
Their passage histories have been described (Chapter 1).
Cell cultures
Rabbit kidney epithelial cell line LLC-RK^ was used to
propagate EHV-1 and EHV-2 for negative contrast TEM. The
source and passage history of the cell line were as described
previously (Chapter 1). Eagle's minimal essential medium
(Sigma Chemical Company, St. Louis, MO) supplemented with 10%
fetal bovine serum, 100 IU of potassium penicillin G and 100
meg of streptomycin sulfate/ml, and buffered to a final
concentration of lOmM NaHCO^ and 25mM HEPES (N-2-hydroxyethyl
piperazine-N-2-ethanesulfonic acid), pH 7.4, was employed as
growth medium. LLC-RK^ cell monolayer cultures were grown in
2
roller bottles (850cm )(Corning Glass Works, Corning, NY).
Pony alveolar macrophage (FPAM) cultures were initiated 
from a near-term pony fetus. The preparation and propagation
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of alveolar macrophages have been described (Chapter 1). FPAM 
cultures were used in the second passage.
Virus inoculation of FPAM cultures
Confluent monolayers of FPAM on glass coverslips (1.2cm 
diameter) in 60 mm plastic tissue culture dishes (Falcon 
Labware Division, Oxnard, CA) were inoculated with 0.4 ml of 
stock EHV-1 (approximately 5X10^ TCID,.q) or EHV-2 (approximate­
ly 3x10^ TCIDj.q) per coverslip. After absorption for 1 h at 37 
C, the inoculum was removed and cell monolayers were washed 
twice in. phosphate-buffered saline, pH 7.4, and 3 ml of growth 
medium was added.
Organ cultures
Methods used in acquiring, initiating, and infecting fetal 
(FlMl) and adult (Al) pony respiratory organ cultures (nasal, 
pharyngeal, tracheal) were described (Chapter 1). Briefly, 
tracheal rings and sections of nasal and pharyngeal tissue were 
inoculated with EHV-1 or EHV-2 and maintained in Leibovitz's 
L-15 medium at 37 C for 14 days.
Electron Microscopy
For negative staining of EHV-1 or EHV-2, virus-infected 
monolayer cultures of LLC-RK^ cells showing 75-95% CPE were 
rapidly frozen and thawed twice in a dry ice-ethanol bath.
The virus-rich cellular suspension thus obtained was clarified 
by centrifuging at 10,410g for 20 min in a Sorval refrigerated 
centrifuge (Ivan Sorval, Inc, Newton, Conn). The pellet 
(consisting mainly of cellular debris) was discarded and the 
virus-rich supernate was centrifuged at 53,900g for 2.5 h
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in a Beckman ultracentrifuge (Beckman Spinco division,
Palo Alto, CA). The supernatant fluid was discarded, and the 
virus-rich pellet was resuspended in 0.1 M Na^PO^ buffer, pH 
7.2, and homogenized by vigorous shaking on a vortex mixer 
(Scientific Industries, Inc, Bohemia, NY). The virus prepara­
tion was nebulized on carbon-coated grids, stained with 4% 
phosphotungstic acid, dried under vacuum, and examined in Zeiss 
EM-10 transmission electron microscope (Zeiss, Inc, New York).
For thin section electron microscopy, infected and unin­
fected control organ culture samples were processed according
13to the method of O'Niell et al, with a slight modification. 
Briefly, the samples were fixed for 1 h in a mixture of 2% 
formaldehyde and 1.25% glutaraldehyde in 0.1 M sodium 
cacodylate buffer, pH 7.4, containing 5% sucrose. They were 
post fixed in 1% osmium tetroxide, treated with 1% tannic acid 
mordant for 1 h at ambient temperature, dehydrated through a 
graded series of ethanol, and embedded in epon-araldite mix­
ture. Thin sections were stained sequentially with uranyl 
acetate and lead citrate prior to examination with a Zeiss 
EM-10 Transmission Electron Microscope at 80kV.
At various intervals, cell and organ culture samples were 
fixed at ambient temperature for 30 min (FPAM) or 1 h (organ 
cultures) in a mixture of 2% formaldehyde and 1.25% glutaralde­
hyde in 0.1M sodium cacodylate buffer, pH 7.4, containing 5% 
sucrose. After post fixation in 1% osmium tetroxide for 1 h,
samples were gradually dehydrated in ethanol (30% to 100%),
13processed for SEM as described by O'Niell et al examined in
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an S150 MARK 2 scanning electron microscope (Cambridge 
Instruments, Monsey, NY) at an acceleration voltage of 20kV.
RESULTS
Capsid morphology and morphogenesis
Cursory examination of negative stained virus revealed 
that capsids of EHV-1 and EHV-2 were spherical and 
morphologically similar measuring approximately lOOnm in 
diameter. Each capsid consisted of ring-shaped capsomeres each 
of which measured approximately 12nm in external diameter.
Three capsids of EHV-2 are shown (Fig la), and a capsid of the 
virus is presented with capsomeres in radial arrays (Fig lb). 
Capsids of EHV-1 are shown (Fig lc) one of which possesses 
outer and middle capsid layers as well as an electron dense 
core. Enveloped virions were not observed in the negative 
stain preparations.
Analysis of fetal (FlMl) nasal cultures at 4 days post 
inoculation (DPI) by TEM showed EHV-2 capsids (mostly contain­
ing dense cores) in the nucleus of infected cells (Fig 2). 
Clusters of viral particles were observed in cytoplasmic 
vacuoles and some of these were released into the extracellular 
space together with an electron dense amorphous material (Figs 
3 and 4). Enveloped viral particles had diameters that ranged 
from 125 to about 150 nm. A network of cytoplasmic fibrils 
was observed in infected cells (Fig 5) and some of the fibrils 
appeared to originate from the nucleus close to the nuclear 
envelope (Fig 2).
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Surface alterations in virus infected FPAM.
Morphology of a normal second passage macrophage (FPAM) 
monolayer by SEM is shown (Fig 6). The flattened cells are 
attached to the substrate and are in close contact with each 
other. In virus infected FPAM, cell rounding and retraction 
from the substrate were first observed at 24 and 72 HPI for 
EHV-1 and EHV-2 respectively (Figs 7 and 8). Several virus-like 
particles with approximate diameters of 180 nm were seen on the 
plasma membrane of cells infected with EHV-1 and EHV-2 
respectively (Figs 9 and 10).
Surface alterations in virus infected organ cultures 
Morphology of uninfected cultures:
The surface features of uninfected control nasal turbinate 
epithelium as observed by SEM were essentially the same for 
cultures derived from both fetal and adult equine sources. 
Ciliated cells occurred in patches with the intervening spaces 
occupied by non ciliated cells that had numerous microvilli. 
Glandular openings were also interspersed in the epithelium 
(Figs 11 and 12). Uninfected control tracheal epithelium from 
an adult pony (Al) had many furrows (Fig 13) as compared with 
relatively few in that from fetal (FlMl) origin (Fig 14). The 
epithelium of fetal and adult tracheal rings were more uniform­
ly ciliated than in nasal sections (Fig 15). Control FlMl 
pharyngeal epithelium (Fig 16) had numerous glandular openings 
bordered by squamous epithelial cells. At a high magnifica­
tion, microplicae, or microfolds, were evident on squamous 
epithelial cells (Fig 17).
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Morphology of EHV-1 Infected Al cultures:
EHV-1 induced surface changes were observed within 2 days 
in infected nasal and tracheal cultures. The changes which 
increased in severity with time were characterized by rounding 
and lysis of epithelial cells (Figs 18 and 19). By 10 DPI, 
many areas of the surface of infected nasal and tracheal 
cultures were devoid of epithelial cells (Fig 20 and 21). At 
10 DPI rounded ciliated cells and cells with shortened cilia 
were observed in infected tracheal epithelium (Fig 22). 
Ciliated and non ciliated cells were absent from the 
epithelium of infected tracheal cultures at 14 DPI and what 
appears to be the basal lamina was exposed (Fig 23).
Morphology of EHV-2 infected FlMl cultures:
Pharyngeal epithelium 2 days after inoculation with EHV-2 
(Fig 24) displays surface squamous epithelial cells in the 
process of being desquamated. At 4 DPI the epithelium was 
elevated in areas of extensive cell rounding and probable cell 
proliferation (Fig 25). Such elevations were absent in 
uninfected control cultures (Fig 26). AT 6 DPI, the fragile 
upper layer of the stratified squamous epithelium of 
both infected and uninfected pharyngeal cultures peeled off 
during aldehyde fixation (not shown).
EHV-2 induced cytopathic changes in infected nasal cul­
tures were first observed at 4 DPI. The changes included 
shedding of epithelial cells and cell rounding (Fig 27). A 
higher magnification of the central region of figure 27 (in
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legend and photo) revealed numerous spherical virus-like 
particles which measured 140-190nm in diameter (Fig 28). 
Extensive rounding and loss of epithelial cells were observed 
at 14 DPI in infected nasal cultures (Fig 29), but ciliated 
cells were still present (Fig 30).
Cytopathic changes in EHV-2 infected tracheal cultures 
were observed as early as 4 DPI and consisted mainly of round­
ing of epithelial cells (Fig 31). At 6 DPI many foci of 
rounded cells were observed (Fig 32), and by 14 DPI there was 
widespread rounding of tracheal epithelial cells (Fig 33).
DISCUSSION
The upper and lower respiratory tract of horses is con­
tinually cleansed by a mucociliary mechanism which traps 
viruses and other particulate matter and transports them to the 
pharyngeal region where they may be swallowed. Virus particles 
which bypass the cleansing system may reach the lung where they 
may encounter alveolar macrophages and be phagocytosed. 
Impairment of the mucociliary mechanism resulting from virus 
infection may promote growth of secondary invaders such as 
bacteria or other viruses. Additional loss to respiratory 
function could be caused by loss of phagocytic function of 
alveolar macrophages as a result of virus multiplication and 
persistence.
Organ cultures of portions of pony respiratory tract 
(nasal, pharyngeal, tracheal) and monolayer cultures of pony
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alveolar macrophages (FPAM) were used in the present study to 
investigate the pathogenesis of EHV-1 and EHV-2 infections. To 
date, there are no SEM and TEM studies of EHV-2 infections in 
organ cultures, and only few reports are available on the 
ultrastructural relationship between EHV-1 and equine respi­
ratory organ cultures.
Although host defense mechanisms such as immune and 
inflammatory responses may be lacking in organ cultures, the 
presence of live and fully differentiated cells in these 
cultures suggest that the in vivo character is not completely 
destroyed. In organ cultures cells retain their normal 
histological appearance and their functional activity as judged 
by mucus production and ciliary activity. Previous work has 
shown that infections in organ cultures may closely approximate 
what occurs in the intact animal.^**'*’ For example, in one 
report growth of infectious bovine rhinotracheitis virus was 
recorded in bovine tissues derived from various anatomic 
locations. The greatest growth occurred in nasal, tracheal, and 
vaginal epithelia, and the histopathological changes induced in 
these cultures resembled those found in natural disease.^
Cytopathic effects were observed in this study following 
infection of FPAM by both EHV-1 and EHV-2, and both viruses 
also destroyed epithelium of the respiratory cultures. The 
magnitude and kinetics of cell damage varied between the two 
viruses with EHV-2 being less cytopathic and taking more time 
to produce equivalent histopathology. These results are in
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agreement with the observation that EHV-2 exhibits delayed 
cytopathology in cultured cells.^
Epithelial damage due to EHV-1 was severe and extensive. 
This finding is consistent with a reported widespread necrosis
of epithelial cells in the upper respiratory tract in acutely
1 13infected horses. In SEM studies, O'Niell et al did not
find ciliated cells at 6 DPI in EHV-1 infected fetal horse
tracheal cultures, whereas in the present study ciliated cells
were observed at 10 but not 14 DPI in infected adult pony (Al)
tracheal cultures. The persistence of ciliated cells in
infected Al cultures for longer than 6 DPI could have been due
to the cultures having immune protection by virtue of being
derived from a seropositive donor. Another possibility is that
EHV-1 affects fetal respiratory tissue more severely than it
does adult respiratory tissue because virus specific receptors
may be present in larger numbers in fetal than in adult
respiratory tissue. Alternatively, the cell metabolic
machinery in fetal tissues may be more favorable to EHV-1
growth. Other contributory factors may be the absence of
mucosal immunity in fetal tissues due to lack of IgA producing
cells, although fetuses can produce IgM and IgG antibodies that
can act during the viremic stage of virus infections. Poor
interferon production by fetal cells, or poor antimicrobial
responses of fetal phagocytic cells may also contribute to the
high susceptibility of fetal tissues to virus infection.
The extensive destruction of tracheal and nasal epithelia 
by EHV-1 could result in the breakdown of an important
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component of the respiratory tract defense mechanism namely the 
mucociliary clearance system. The breakdown of this system may 
allow more time for the attachment of bacteria to respiratory 
tissue, and their subsequent multiplication in this site.
Also, following EHV-1 infection, bacterial-specific receptors 
may be exposed on epithelial cells thus facilitating bacterial 
adherence to these cells. When these processes occur in vivo, 
a severe bacterial pneumonia may result.
Epithelial damage due to EHV-2 was demonstrated in 
pharyngeal, nasal and tracheal cultures. EHV-2 morphogenesis 
was also observed in thin sections of infected nasal cultures. 
Replication of EHV-2 in respiratory organ cultures coupled with 
the observed EHV-2 induced cytopathic changes in FPAM and organ 
cultures suggest that EHV-2 is potentially pathogenic. Surface 
alterations in the organ cultures may be a pathologic basis for
the clinical signs seen after natural or experimental infect-
* i 3,5 ions in young foals.
In SEM images of pharyngeal epithelial cells, interesting 
surface structures were observed. At higher magnification, 
numerous ridge-like folds of the plasma membrane called 
microplicae, or microfolds, could be distinguished. Inter- 
digitations of these microfolds among adjacent or overlying 
cells may serve to organize the cells into sheets of stratified 
epithelia. Since stratified epithelia are subject to wear and 
tear, the microfolds may play a role in reducing the frictional 
area between the plasma membranes of adjacent cells and in 
trapping lubricating fluids such as mucin.^
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It has been proposed that superficial cells in stratified 
epithelium can more easily desquamate than underlying cells.^ 
The explanation given was that in deeper layers of the 
epithelium desmosomes are associated with many of the 
microplicae whereas in the more superficial layers fewer 
desmosomes are present. As a result, adhesion is considerably 
reduced among the superficial cells. Viruses whose portal of 
entry into a host does not involve the pharynx may be prevented 
from establishing infection at this site by desquamation of 
superficial cells. This mechanism could account in part for 
the observed clearance of EHV-2 from infected pharyngeal 
cultures from post inoculation day 5 (Chapter 1).
The diameter of capsids of both EHV-1 and EHV-2 as
measured in electron micrographs of negative stain preparations
was approximately lOOnm, and the 12nm external diameter of the
18ring-shaped capsomeres was similar to other herpesviruses. 
Virions of EHV-1 and EHV-2 budding from the plasma membrane of 
macrophages had an approximate diameter of 180nm. Capsid 
morphogenesis of EHV-2 was observed in the nucleus of infected 
nasal epithleial cells but the process of envelopment at the 
nuclear membrane was not seen. Several enveloped virions within 
cytoplasmic vacuoles were present, and many were released 
laterally into intercellular spaces and apically into the 
culture medium. This finding could explain the recovery of 
EHV-2 in high amounts from infected cell and organ cultures 
during the growth kinetic studies (Chapter 1).
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Although some pathogenic properties of EHV-1 and EHV-2 
have been demonstrated in the present work, future studies with 
either of these agents should be coupled with animal experi­
ments for a better appreciation of the pathogenic mechanisms 
involved in respiratory virus infections. This will be espe­
cially important for investigations involving diseases in which 
immune and inflammatory responses play a significant role in 
determining the outcome of infection.
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APPENDIX 
Chapter II: Figures
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Abbreviations used in the figures:
EHV-1 = Equine herpesvirus type 1
EHV-2 = Equine herpesvirus type 2
FPAM = Fetal pony alveolar macrophage
F1M1 = Fetal pony organ culture
A1 = Adult pony organ culture
HPI = Hours post inoculation
DPI = Days post inoculation
TEM = Transmission electron microscopy
SEM = Scanning electron microscopy
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Fig 1 - Negatively stained EHV-1 and EHV-2 showing capsids without 
an envelope.
a - Three capsids of EHV-2 illustrate the ring-like 
capsomeres, morphological subunits of the viral 
protein coat.
b - A capsid of EHV-2 shows capsomeres in radial array, 
c - Capsids of EHV-1 are shown. One capsid (X) is
penetrated by phosphotungstic acid stain and reveals 
outer and middle capsid layers. TEM,
a - bar = 50 nm; b - bar = 50 nm; c - bar = 50 nm.
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Fig 2 - EHV-2 infected F1M1 nasal epithelium at 4 DPI. Viral 
morphogenesis is evident in this micrograph. Nucleocapsids (large 
arrows) are present in the nucleus (N) of an infected cell, and 
viral particles (small arrows) are seen, outside the cell. Fibrils 
(F) in longitudinal and cross section are observed in the 
cytoplasm (C) and they appear to be inserted in the nuclear 
envelope (NE). TEM, bar = 0.5 pm.
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Fig 3 - EHV-2 infected F1M1 nasal epithelium at 4 DPI. A cluster
of complete viral particles (large arrow) is being transported in
the cytoplasm of an infected cell. Complete viral particles 
(small arrows) and an amorphous material (A) are identified in the 
micrograph. N = nucleus, C = cytoplasm, M = mitochondrion. TEM, 
bar = 0.5 ym.
Fig 4 - EHV-2 infected F1M1 nasal epithelium at 4 DPI. A cluster
of viral particles (same as in Fig 3) at high magnification, 
illustrating details of virion morphology. An incomplete particle 
(arrow) appears sequestered in a separate vacuole. N = nucleus, C 
= cytoplasm, M = mitochondrion. TEM, bar =0.5 ym.
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Fig 5 - EHV-2 infected F1M1 nasal epithelium at 4 DPI. 
Intracytoplasmic fibrils (F) in longitudinal and cross section are 
shown in two adjacent cells. Two sites (large arrows) of viral 
buds on the plasma membrane are indicated, and three complete 
viral particles (small arrows) are seen at an intercellular 
location. TEM, bar = 0.5 pm.
Fig 6 - Surface view of uninfected FPAM monolayer. Cells are 
flattened, and in close contact with each other. SEM.
f
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Fig 7 - EHV-1 infected FPAM monolayer at 24 HPI. Cytopathic 
changes consist of rounding of cells. In addition some cells have 
extended long cytoplasmic processes (arrows) and are retracting 
from the glass substrate. SEM.
Fig 8 - EHV-2 infected FPAM monolayer at 72 HPI. Cells are in the 
process of rounding, and a few of them are extending long 
cytoplasmic processes (arrows). Empty spaces (E) are observed in 
areas of cell retraction from the glass substrate. SEM.
VFig 7
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Fig 9 - EHV-1 infected FPAM monolayer at 24 HPI. Viral particles 
are present on the surface of an infected cell. SEM.
Fig 10 - EHV-2 infected FPAM monolayer at 72 HPI. Fenestrations 
(small arrows) representing areas of apparent plasma membrane 
damage, and viral particles (large arrows) are prominent on the 
surface of an infected cell. SEM.
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Fig 11 - Surface view of uninfected F1M1 nasal epithelium at low 
magnification. Ciliated cells (small arrows) and glandular 
openings (large arrows) are interspersed in the epithelium. SEM.
Fig 12 - Surface view of uninfected F1M1 nasal epithelium at high 
magnification. Two types of cells are seen, non ciliated 
polygonal cells with numerous microvilli (M), and cells possessing 
cilia (C). A glandular opening (arrow) is identified. SEM.
f
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Fig 13 - Uninfected A1 tracheal epithelium at low magnification. 
Many furrows are seen. SEM.
Fig 14 - Uninfected F1M1 tracheal epithelium at low magnification. 
The epithelium is covered with a blanket of cilia. The cut edge 
of the tissue (arrow) is shown. SEM.
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Fig 15 - Uninfected A1 tracheal epithelium at high magnification. 
The epithelium is uniformly ciliated. An opening (arrow) of a
tracheal gland is shown. SEM.
Fig 16 - Uninfected F1M1 pharyngeal epithelium at low
magnification. The orifices of pharyngeal glands bordered by
squamous cells (arrows) are indicated in the micrograph. SEM.
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Fig 17 - Uninfected F1M1 pharyngeal epithelium at high 
magnification. At this magnification, a pattern of folds (large 
arrows) called microplicae is apparent on the surface of cells. A 
border (small arrows) between adjacent cells is identified. SEM.
i
Fig 18 - EHV-1 infected A1 nasal epithelium at 2 DPI. Cell 
rounding is seen as well as an area of apparent cell lysis 
(arrow). SEM.
J
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Fig 19 - EHV-1 infected A1 tracheal epithelium at 2 DPI. Rounded 
cells (large arrows) are seen, and the border (small arrows) 
between an area of cytopathic alterations and one lacking such 
changes is shown. SEM.
Fig 20 - EHV-1 infected A1 nasal epithelium at 10 DPI.
Epithelial cells are virtually absent leaving an exposed basement 
membrane (B). Rounded cells (small arrows) in the process of 
being shed, and openings (large arrows) of nasal glands are shown. 
SEM.
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Fig 21 - EHV-1 infected A1 tracheal epithelium at 10 DPI.
Ciliated cells (arrows) are lacking in parts of the epithelium, 
and many of those present exhibit abnormal morphology as depicted 
in Fig 22. SEM.
Fig 22 - EHV-1 infected A1 tracheal epithelium at 10 DPI. A cell 
(R) in the process of rounding manifests ciliary resorption or 
arrested development of cilia. SEM.
136
Fig 22
137
Fig 23 - EHV-1 infected A1 tracheal epithelium at 14 DPI.
Extensive loss of ciliated and non ciliated cells has occurred 
leaving and exposed basement membrane (B). SEM.
Fig 24 - EHV-2 infected F1M1 pharyngeal epithelium at 2 DPI. Many 
regions of the epithelium display cells (arrows) in the process of 
being shed by desquamation. SEM.
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Fig 25 - EHV-2 infected F1M1 pharyngeal epithelium at 4 DPI. 
Extensive degeneration and/or proliferation of cells are prominent 
after virus infection, in contrast to minimal surface alterations 
in uninfected control epithelium (Fig 26). SEM.
Fig 26 - Uninfected control F1M1 phayngeal epithelium at 4 DPI. 
The epithelium displays minimal surface changes as compared with 
that infected with EHV-2 (Fig 25). SEM.
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Fig 27 - EHV-2 infected F1M1 nasal epithelium at 4 DPI. Various 
cells are in the process of rounding. The demarcated area is 
enlarged in Fig 28. CC = ciliated cell, NC = non ciliated cell, 
RC = rounded cell, CM = cell with surface microvilli, 0 = opening 
of nasal gland, SD = secretory droplets. SEM.
Fig 28 - EHV-2 infected F1M1 nasal epithelium at 4 DPI. An 
enlargement of the demarcated area in Fig 27 reveals many 
virus-like particles or viral buds on the surface of infected 
cells. SEM.
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Fig 29 - EHV-2 infected F1M1 nasal epithelium at 14 DPI.
Extensive rounding of cells is evident. Loss of ciliated and non 
ciliated cells has occurred at various regions of the epithelium 
leaving an exposed basement membrane (B). SEM.
Fig 30 - EHV-2 infected F1M1 nasal epithelium at 14 DPI. A region 
of the epithelium where the basement membrane is unexposed reveals 
rounded cells and cells with attenuated cilia. SEM.
i
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Fig 31 - EHV-2 infected F1M1 tracheal epithelium at 4 DPI.
Rounded cells (small arrows) and ciliated cells (large arrows) are 
identified. SEM.
Fig 32 - EHV-2 infected F1M1 tracheal epithelium at 6 DPI. Many 
foci (F) of rounded cells and a few ciliated cells (arrows) are 
present. SEM.
146
Fig 31
Fig 32
Fig 33 - EHV-2 infected F1M1 tracheal epithelium at 14 DPI. 
Rounding of epithelial cells is widespread. SEM.
Fig 33
CHAPTER III
EQUINE HERPESVIRUS TYPE 2: KINETICS OF CYTOSKELETAL
AND CYTOPATHIC CHANGES IN PONY 
ALVEOLAR MACROPHAGE CULTURES
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SUMMARY
Changes in the organization of microfilaments (MF) and 
microtubules (MT) were studied by indirect immunofluorescence 
microscopy and compared with the kinetics of cytopathic effects 
(CPE) in monolayer cultures of pony alveolar macrophages 
infected with equine herpesvirus type 2 (EHV-2). In uninfected 
cultures, MF were observed as parallel bundles of actin 
filaments that ran from one end of a cell over the nucleus to 
the other end, and MT appeared as pale radiating filaments that 
seemed to originate from the nuclear region. Cytoskeletal 
changes after synchronized high multiplicity infection consisted 
of the disruption of MF and MT (characterized by diffuse 
staining of actin and tubulin) and a concomittant disappearance 
of filaments. Changes in the organization of MF and MT were 
detected earlier than CPE (cell rounding and polykaryocytosis), 
but at the time of appearance of CPE the same proportion of 
cells in the monolayer displayed morphological alterations and 
cytoskeletal changes. From the onset of CPE, cytoskeletal and 
cytopathic changes proceeded in parallel.
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INTRODUCTION
Infection of susceptible cultured cells with equine
herpesviruses results in the prodution of cytopathic effects
(CPE) manifested as cell rounding and, occasionally, syncytium
1 2formation (polykaryocytosis). * The underlying mechanisms of
virus-induced cell morphology changes remain largely unknown.
Results of previous studies suggest that cytoskeletal changes
3-11may be involved in CPE and cell transformation.
Immunofluorescence microscopy has been used to study the
organization and distribution of microfilaments (MF) and
5 9-11microtubules (MT) in normal and virus infected cells. ' The
present study was designed to examine and compare kinetics of 
changes in the organization of MF and MT, and the production of 
CPE in equine herpesvirus type 2 (EHV-2) infected pony alveolar 
macrophages in vitro.
MATERIALS AND METHODS
Virus
The source of EHV-2 and propagation of the virus in rabbit 
kidney (LLC-RK^) cells have been described (Chapter 1).
Cell cultures
The source and preparation of pony alveolar macrophages 
were as described (Chapter 2). Macrophages were grown as 
monolayer cultures (4th subpassage) on Lab-Tek tissue culture 
chamber slides (Lab-Tek Products, Miles Laboratories,
Inc, Naperville, Illinois). Constituents of growth medium 
for the cells were described (Chapter 1).
151
152
Virus inoculation of macrophage monolayers
Macrophage monolayers on Lab-Tek 8-chamber slides were 
inoculated with EHV-2 at a multiplicity of infection of 
approximately 190. After adsorption for 1 h at 37 C, the slides 
were washed twice in Eagle's minimum essential medium containing 
100 IU of potassium penicillin G and 100 meg of streptomycin 
sulfate/ml, and 0.4 ml of growth medium was added to each 
chamber. Slides were maintained for various periods at 37 C in 
a humidified incubator.
Immunoreagents
Pooled unabsorbed anti-actin and anti-tubulin antisera 
raised in rabbits, and fluorescein isothiocyanate 
(FITC)-conjugated goat anti-rabbit IgG were obtained from a 
commerical source (Miles Scientific, Miles Laboratories, Inc, 
Naperville,Illinois). Working dilutions of the reagents were 
1:10 (anti-actin and anti-tubulin) and 1:16 (FITC-conjugated 
anti-rabbit IgG).
Immunofluorescence
Cells in chambers of the Lab-Tek slides were processed for
14indirect immunofluorescence as described by Saf.ake et al, but 
with a slight modification. The cells were fixed for 20 minutes 
at ambient temperature in 4% formaldehyde in phosphate-buffered 
saline(PBS), pH 7.4, and stored at 4C. Later, they were rinsed 
in PBS and immersed in acetone: H^O (1:1) for 2 min, acetone for 
5 min, and acetone: ^ 0  (1:1) for 2 min, all at -20C. Cells 
were incubated with the specific antibody(anti-actin or 
anti-tubulin) at 37C for 1 h followed by FITC-conjugated 
anti-rabbit IgG for 30 min. The cells were examined with a
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Zeiss model 9901 photomicroscope (Zeiss, Inc, New York); 
photographs were taken on Kodak Plus-X film.
RESULTS
Distribution of actin
Parallel bundles of actin filaments passing over the 
nucleus and extending from one end of a cell to the other along 
the major axes were seen in uninfected cultures (Fig 1). At 36 
hours post inoculation (HPI) with EHV-2, cells displayed intense 
and diffused immunofluorescent staining and only few actin 
filaments remained (Fig 2). Also the cells appeared to retract 
from the substrate and actin staining was noted at the 
periphery of cells. At 72 HPI actin filaments essentially 
disappeared and polykaryocytosis was noted(Fig 3).
Distribution of tubulin
The staining pattern of tubulin in uninfected cells 
consisted of numerous pale filaments which appeared to radiate 
out from the nuclear region and extend in parallel bundles along 
the major cell axes (Fig 4). Tubulin staining was pale inside 
the nucleus but more intense at the perinuclear area (Fig 4). 
Infected cells at 36 HPI possessed fewer MT.(Fig 5). At 72 HPI, 
there was intense and diffuse tubulin staining in addition to 
polykaryocytosis and disappearance of filaments (Fig 6). 
Kinetics of cytoskeletal and cytopathic changes
Disruption of the cytoskeleton after EHV-2 infection 
occurred as early as 24 and 36 HPI for MF and MT respectively 
and CPE (cell rounding and polykaryocytosis) were first noticed
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at 48 HPI (Table 1). At 48 HPI the proportion of monolayer 
showing cytoskeletal and cytopathic changes was the same; from 
this time, changes in organization of cytoskeletal elements and 
CPE proceeded in parallel.
DISCUSSION
Immunofluorescence microscopy provides a simple and rapid 
means of visualizing the cytoskeleton in large populations of 
cells. By this technique we have demonstrated disruption of two 
cytoskeletal elements (microfilaments and microtubules) in 
cultivated pony alveolar macrophages infected with EHV-2.
Changes in organization of cytoskeletal elements were detected 
earlier than visible cytopathic effects (CPE).
Immunofluorescent staining patterns of MF and MT in the present 
study are in agreement with those described previously in 
transformed,^ virus-infected,*^ and uninfected cells.*"*
The variety of virus-induced cell changes termed CPE refer 
mainly to those morphological changes observable at the level of 
light microscopy. The changes may vary for different viruses or 
virus strains. For example, poliovirus and vesicular stomatitis 
virus cause cell rounding, whereas members of the paramyxovirus 
group induce polykaryocytosis as a result of cell fusion. *** 
Infections with the Lennette strain of herpes simplex virus 
(HSV)-l result in cell rounding while the IES strain of HSV-1
3
induces polykaryon formation. EHV-2 caused both polykaryo­
cytosis and cell rounding.
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The mechanism by which cell fusion is induced by EHV-2 is not
known. It has been proposed that herpesviruses demonstrate only
"fusion from within", that is, fusion resulting from de novo
synthesis of viral products, in contrast to "fusion from
without" which can occur without virus multiplication. Since
purified herpes virions have not been reported to cause fusion
of cells, it has been suggested that fusion may be caused by a
non-structural viral protein which appears on the surface of 
16infected cells. In constrast to the limited knowledge of cell 
fusion by herpesviruses, the paramyxovirus model of cell fusion 
is widely studied and was reviewed by Schrom and Balanian.^
The envelope of paramyxoviruses contains two glycoproteins which 
consist of spike-like projections on the surface of the virion. 
One of the glycoprotein spikes, HN, is responsible for 
receptor-binding (hemagglutinating) activity, while the other,
F, is responsible for fusion activity and associated activities 
in cell penetration as well as hemolysis. The F polypeptide is 
activated by a host protease to yield two fragments, F^ and F^ 
which remain associated by disulfide bonds. The cleavage 
generated amino terminus of F^  appears to be responsible for the 
fusion activity.
The involvement of MF and MT in virus-induced cell rounding 
during transformation has been studied extensively but 
relatively few studies have been carried out concerning the role 
of the cytoskeleton in viral CPE. Rounded transformed cells 
have been shown in previous work to display a considerable
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reduction in the number of MT,^’^  suggesting an inability of 
these cells to assemble cytoplasmic MT and maintain normal cell 
morphology. The two main approaches employed to study the 
relationship between cytoskeletal changes and CPE are the 
microtubule paracrystal (PC) and indirect immunofluor­
escence assays. The basis for the PC assay is that treatment of 
cultured cells with vinblastine sulphate (a drug which binds 
to the microtubule subunit tubulin) induces formation of large
microtubule paracrystals detectable under a phase-contrast
17 18 8microscope. ’ Ebina et al reported that inhibition of PC
formation and the appearance of CPE (cell rounding and
disappearance of nucleoli) proceeded in parallel in HSV-infected
HeLa-S3 cells. In the same report, these effects of HSV were
blocked by cycloheximide (a protein synthesis inhibitor) but not
by inhibitors of DNA synthesis. The investigators concluded
that an "early" protein coded by the input virus genome
inhibited PC formation and was responsible for the CPE. In
3
contrast to the observation of Ebina and coworkers, Heeg et al 
observed vinblastine-induced PC in rabbit kidney cells infected 
with HSV strains that produced either cell rounding or 
polykaryocytosis. The difference was attributed to either the 
cell type or the amount of virus used to initiate infection.
The authors also noted that virus replication was accompanied by 
rearrangement of MT and production of CPE (polykaryocytosis) and 
suggested that these effects were caused by early or late 
virus-coded proteins.
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Howard et al used antibodies against MF, MT, vimentin and 
keratin filaments as immunofluorescent probes to compare 
cytoskeletal organization in canine distemper virus (CDV)- 
infected and uninfected Hep-2 cells. Their study demonstrated 
that CDV disrupted all the cytoskeletal elements and also 
produced CPE (polykaryocytosis) in infected cells. The 
investigators were, however, unable to determine the order in 
which cytoskeletal and cytopathic changes occurred as a kinetic 
comparison was not performed. In our study, disruption of MF 
and MT were seen earlier than CPE, but at the time of 
appearance of CPE the proportion of cell monolayer displaying 
cytoskeletal and cytopathic changes was the same. After this 
time, both changes proceeded in parallel. The utility of 
cytoskeletal changes as opposed to CPE in detecting or 
predicting infections by slowly cytopathic viruses such as EHV-2 
and cytomegaloviruses may be suggested from our results.
In the present study both actin and tubulin staining were
observed in the cytoplasm of uninfected cells with intense
perinuclear distribution of tubulin while only tubulin
staining was detected in the nucleus. It appears from these
observations that actin may be absent or present in very low
amounts in the nucleus. Our results are somewhat in agreement
with previous immunofluorescence studies involving cycling 
19cells. Actin and other microfilament associated proteins were 
absent in the mitotic spindle but appeared during cytokinesis in 
the cleavage furrow. It was suggested that actin and 
microfilament-associated proteins may not be a major constituent
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of the mitotic spindle. Brinkley et al ^  provided evidence for 
two separate microtubule entities in cycling cells: a
cytoplasmic microtubule complex, and microtubules of the mitotic 
spindle. Although an interchange of tubulin dimers was believed 
to exist between MT in the nucleus and cytoplasm, control of MT 
assembly was thought to be under separate constraints. The 
significance of nuclear MT in monolayer cultures of alveolar 
macrophages having low cell turnover may need further 
investigation.
20Recently, .Sharp et al reported a reorganization of 
vimentin filaments but not MT in reovirus infected monkey kidney 
CV-1 cells indicating that not all components of the 
cytoskeleton may be equally affected by all viruses. This
4
observation is in contrast to the findings of Howard et al 
where both vimentin and MT were disrupted in Hep-2 cells after 
infection with CDV. In the present study MT and MF were 
disrupted in cultured pony alveolar macrophages infected with 
EHV-2. It seems likely that the characteristics of the 
individual virus may determine which cytoskeletal elements are 
reorganized during cytocidal virus infections. Probably tubulin 
glycosylation or envelope-associated proteins specified by EHV-2 
and CDV (enveloped viruses) may be responsible for 
depolymerization of MT. Reoviruses (naked viruses) most likely 
do not specify the synthesis of such proteins and therefore do 
not cause disruption of MT.
The mechanism of virus-induced disruption of MT and MF in 
cytocidal virus infections is unknown. It is likely that
159
virus-specified products may be involved. These products could
behave in a manner similar to that of drugs which cause
depolymerization of MT and MF, or those that prevent assembly of
cytoskeletal subunits. The two drugs colchicine and colcemid
(N-desacetyl-N-methyl colchicine) inhibit the assembly of
tubules and they are believed to form a complex with the free
21tubulin dimer and interfere with its ability to polymerize, 
in one study when 3T3 cells were treated with colcemid for 2h,
MT essentially disappeared or became greatly diminished, cells 
lost their fibroblastic morphology and assumed a rounded and 
knobby appearance.^ In another study, the sustained release of 
insulin by cultured pancreatic cells was depressed when 
colchicine was added to the culture medium.^ These experiments 
suggest that MT are involved in maintenance of cell shape and 
that they may also play an important role in intracellular 
transport of secretory products. Further studies are indicated 
concerning the effect of metabolic inhibitors on the interaction 
between EHV-2 and the cytoskeleton. Results of such studies 
will provide valuable insight into not only how CPE is produced 
by cytocidal viruses, but also how cell shape and macromolecular 
transport are controlled.
BIBLIOGRAPHY
1. Bagust TJ: The equine herpesviruses. Vet Bull
41: 79-92, 1971.
2. Studdert MJ: Comparative aspects of equine
herpesviruses. Cornell Vet 64: 94-122, 1974.
3. Heeg U, Hasse W, Brauer D, Falke D: Microtubules and
microfilaments in HSV-infected rabbit kidney 
cells. Arch Virol 70: 233-246, 1981.
4. Howard JM, Eckert BS, Bourguignon LYW: Comparison of
cytoskeletal organization in canine distemper 
virus-infected and uninfected cells. J Gen Virol 64: 
2379-2385, 1983.
5. Fagraeus A, Tyrrell DLJ, Norberg R, Norrby E: Actin
filaments in paramyxovirus-infected human 
fibroblasts studied by indirect
immunofluorescence. Arch Virol 57: 291-296, 1978.
6. Holmes KV, Choppin PW: On the role of microtubules in
movement and alignment of nuclei in virus-induced 
syncytia. J Cell Biol 39: 526:541, 1968.
7. Rutter G, Mannweiler K: Alterations of
actin-containing structures in BHK-21 cells 
infected with Newcastle disease virus and 
vesicular stomatitis virus. J Gen Virol 37:
233-242, 1977.
160
161
8. Ebina T, Satake M, Ishida N: Involvement of
microtubules in cytopathic effects of animal 
viruses: early proteins of adenovirus and
herpesvirus inhibit formation of microtubular 
paracrystals in HeLa-S3 cells. J Gen Virol 38:
535-548, 1978.
9. Carley WW, Barak LS, Webb WW: F-actin aggregates in
transformed cells. J Cell Biol 90: 797-802, 1981.
10. Brinkley BR, Fuller GM, Highfield DP: Cytoplasmic
microtubules in normal and transformed cells in 
culture: analysis by tubulin antibody
immunofluorescence. Proc Natl Acad Sci USA 
72: 4981-4985, 1975.
11. Ball EH, Singer SJ: Association of microtubules and
intermediate filaments in normal fibroblasts and its 
disruption upon transformation by a
temperature-sensitive mutant of Rous sarcoma virus. 
Proc Natl Acad Sci USA 78: 6986-6990, 1981.
12. Cande W, Lazarides E, McIntosh R: A comparison of the
distribution of actin and tubulin in the mammalian
mitotic spindle as seen by indirect immunofluorescence. 
J Cell Biol 72: 552-567, 1977.
13. Edelman GM, Yahara I: Temperature-sensitive changes in
surface modulating assemblies of fibroblasts 
transformed by mutants of Rous sarcoma virus.
Pro Natl Acad Sci USA: 73: 2047-2051, 1976.
162
14. Satake M, Lupo D, Luftig RB: The cytoskeleton of
murine leukemia virus (MuLV)-infected mouse 
fibroblasts as observed under varying conditions 
of formaldehyde fixation. Cell Motil 3:567-577,
1983.
15. Boyd III AE, Bolton WE, Brinkley BR: Microtubules and
beta cell function: effect of colchicine on
microtubules and insulin secretion in vitro by 
mouse beta cells. J Cell Biol 92: 425-434, 1982.
16. Schrom M, Bablanian R: Altered cellular morphology
resulting from cytocidal virus infection. Brief 
review. Arch Virol 70: 173-187, 1981.
17. Bensch KG, Malawista SE: Microtubular crystals in
mammalian cells. J Cell Biol 40: 95-107, 1969.
18. Krishan A, Hsu D: Observations on the association of
helical polyribosomes and filaments with vincristine 
induced crystals in Earle's L-cell fibroblasts. J Cell 
Biol 43: 553-563, 1969.
19. Aubin JE, Weber K, Osborn M: Analysis of actin and
microfilament-associated proteins in the mitotic 
spindle and cleavage furrow of PtK2 cells by 
immunofluorescence microscopy. Exp Cell Res 124: 
93-109, 1979.
20 Sharpe AH, Chen LB, Fields BN: The interaction of
mammalian reoviruses with the cytoskeleton of monkey 
kidney CV-1 cells. Virology 120: 399-411, 1982.
163
21. Bray D, Gilbert D: Cytoskeletal elements in neurons. 
Ann Rev Neurosci 4: 505-523, 1981.
APPENDIX 
Chapter III: Figures and Table
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Abbreviations used in figures:
EHV-1 = Equine herpesvirus type 1
EHV-2 = Equine herpesvirus type 2
FPAM = Fetal pony alveolar macrophage
IF = Immunofluorescence microscopy
(anti-actin antibodies, anti-tubulin 
antibodies, and FITC-conjugated anti-rabbit 
IgG, all obtained from Miles Scientific 
Laboratories Inc., Naperville, Illinois)
HPI = Hours post inoculation
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Fig 1 - Organization of actin in uninfected control FPAM 
monolayer. Note the parallel bundles of actin filaments (arrows) 
running from one end of a cell to the other along the major axis 
of the cell. IF, bar = 20 pm.
Fig 2 - Organization of actin in EHV-2 infected FPAM monolayer at 
36 HPI. Note the disappearance of stainable actin filaments and 
the concomittant increase in diffuse staining of actin. IF, bar = 
20 pm.
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Fig 2
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Fig 3 - Organization of actin in EHV-2 infected FPAM monolayer at 
72 HPI. Cell cytoplasm is essentially free of flourescent actin 
filaments, while diffuse staining predominates. IF, bar = 20 pm.
Fig 4 - Distribution of tubulin in uninfected control FPAM 
monolayer. Cytoplasmic microtubules in parallel arrangement 
appear to originate from a perinuclear region that shows intense 
tubulin staining. IF, bar = 20 pm.
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Fig 5 - Distribution of tubulin in EHV-2 infected FPAM monolayer 
at 36 HPI. Cytoplasmic microtubules have virtually disappeared, 
but nuclear staining (arrows) is present. IF, bar = 20 ym.
Fig 6 - Distribution of tubulin in EHV-2 infected FPAM monolayer 
at 72 HPI. Microtubules are essentially absent in cells, while 
diffuse staining is prominent. Note polykaryocytosis and cell 
rounding. IF, bar = 20 ym.
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Fig 6
Table 1 - Kinetics of cytoskeletal changes and viral cytopathic effects (CPE) 
__________ in EHV-2 infected equine alveolar macrophage cultures.*___________
Percentage of monolayer showing diffusely-stained cells**
Hours after infection Microfilaments Microtubules CPE^
24 10-25 <10 0
36 25-50 10-25 0
48 25-50 25-50 +
72 >95 >95 +++
96 >95 >95 +++
* Monolayer macrophage cultures on Lab-tek chamber slides (Division Miles Labs, Inc., Naperville, 
Illinois) were infected with EHV-2 at an input multiplicity of >_ 190.
** Less than 10% of uninfected monolayer showed the diffused staining pattern in both 
cases (microfilaments and microtubules).
# Rated as follows: + = 25%-50% of monolayer exhibited CPE, +++ = 75%-95% of 
monolayer exhibited CPE.
COMPREHENSIVE DISCUSSION 
The pathogenesis of equine herpesvirus type 2 (EHV-2) 
respiratory infection was studied in cell and organ cultures by 
infectivity assays following experimental infections (growth 
kinetics), and by light, scanning and transmission electron 
microscopy. The kinetics of EHV-2 induced cytoskeletal and 
cytopathic changes were investigated in monolayer cultures of 
fetal pony alveolar macrophages (FPAM) by indirect 
immunofluorescence microscopy. Equine herpesvirus type 1 
(EHV-1) was also studied to provide a comparative model for 
EHV-2 infection. Monolayer cultures of the following cells 
were used: fetal donkey alveolar macrophages (FDAM), fetal
equine (pony) kidney (FEK), rabbit kidney (LLC-RK^), and african 
green monkey kidney (VERO). Organ cultures initiated from 
respiratory tissues (nasal, tracheal, pharyngeal) of 
seronegative pony (F1M1) and donkey (F1D1) fetuses, and a 
seropositive adult pony (Al), were employed in the study,
EHV-2 multiplied in all the cell monolayers reaching peak 
titers earlier in FEK and LLC-RK^ (72 hours post infection) than 
in FDAM and VERO (96 hours post infection). Since alveolar 
macrophages play a pivotal role in pulmonary defense against 
invading microorganisms, it was speculated that EHV-2 
multiplication in these cells in vivo could impair their 
phagocytic and other anti-microbial functions thereby promoting
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invasion of the lung by potentially pathogenic agents such as 
bacteria.
The amount of EHV-2 released from the cell cultures was 
higher (10-fold or more for the peak values) than that from 
organ cultures. Two explanations could account for this 
difference. First, in organ cultures cell types differ and only 
a relatively small proportion might be susceptible to infection. 
Second, the beating of cilia could interfere with the process of 
virus attachment after inoculation and allow for the entry of 
only few viral particles into epithelial cells for virus 
replication.
A further difference in the pattern of growth of EHV-2 in 
cell and organ cultures was the persistence of the virus in 
infected nasal cultures for at least 14 days in F1M1 and 31 days 
in F1D1, in contrast to the steady decline of EHV-2 titers after 
attainment of peak values (3 to 4 days after inoculation) in the 
cell cultures. A possible explanation for EHV-2 persistence in 
the organ cultures could be the production of interferon (IF) in 
quantities sufficient to maintain an equilibrium between EHV-2 
replication and IF concentration. In this case, EHV-2 could 
stimulate certain nasal epithelial cells to produce IF, which in 
turn may inhibit multiplication of the virus, resulting in 
removal of the stimulus for further IF production. The 
subsequent decrease in IF concentration may allow virus 
replication to occur which again stimulates the production of 
IF, and the cycle continues.
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Growth of EHV-2 in nasal and tracheal cultures from the 
different sources showed an inconsistent pattern. In F1M1 
cultures, the virus was released to higher peak titers (over 
10-fold) in nasal than in tracheal cultures whereas in F1D1 
cultures peak EHV-2 titers were essentially the same for both 
cultures. In A1 cultures, EHV-2 was less readily released from 
tracheal cultures and virus multiplication was inhibited in the 
nasal cultures. It must be noted that all cell and organ 
cultures were maintained at 37C in the present study and 
interpretation of organ culture results especially must take 
this into account as a temperature gradient exists in the 
respiratory tract in vivo with a lower temperature in the nasal 
region and a higher temperature in the tracheal region. The 
effect of temperature on virus multiplication in respiratory 
organ cultures may require further investigation.
Multiplication of EHV-2 in F1M1 pharyngeal epithelium was 
negligible although frequent isolation of the virus from 
pharyngeal lymphoid follicles of infected horses have been 
reported. It was suggested that pharyngeal lymphoid follicles 
of infected horses might represent the site of persistence of 
EHV-2. Although limited in scope, the present organ culture 
findings are not consistent with this suggestion and seem to 
implicate nasal epithelium as a more likely site of EHV-2 
persistence with macrophages representing the secondary site of 
persistence of the virus. Constant sloughing of pharyngeal 
cells in the superficial layers may serve to prevent infection 
of the deeper layers of the stratified pharyngeal epithelium
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especially by viruses whose portal of entry may be other than 
the pharynx. On the other hand, blood-borne monocytes infected 
with EHV-2 could transport the virus to the lymphoid follicles 
of the pharynx where it may establish a persistent infection.
Nasal mucosal resistance plays a major role in upper 
respiratory tract defense against microorganisms, as the nasal 
cavity is the portal of entry for most respiratory viruses. As 
judged by EHV-2 multiplication in nasal organ cultures, it was 
interesting to observe that cultures derived from F1M1 appeared 
to be the most susceptible, followed by those from F1D1, and 
then by A1 cultures which did not support the multiplication of 
EHV-2. Nevertheless, in organ cultures, immune and inflammatory 
responses may be largely absent, and infections in these 
cultures may not exactly represent what occurs in the intact 
animal. The above observations on the relative susceptibilities 
indicate that age-dependent resistance may be significant in 
EHV-2 infections, and in vivo studies may be required for 
confirmation. Also, the role of serum neutralizing antibody and 
nasal mucosal secretory IgA levels in protection of horses 
against EHV-2 may need further investigation.
Morphogenesis of EHV-2 in F1M1 nasal organ cultures was 
typical of members of the herpesvirus group. Nucleocapsids of 
the virus were observed in the nucleus of infected nasal 
epithelial cells, and clusters of enveloped virions were seen in 
cytoplasmic vacuoles and in extracellular spaces. Negative 
stain preparations of EHV-2 revealed single and double-shelled 
capsids composed of ring-shaped capsomeres some of which were in
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radial arrays. Enveloped particles were not observed in the 
negative stain preparations probably due to the procedure used 
which could have caused disruption and loss of the viral 
envelope.
EHV-2 induced cytopathic changes in the cell monolayers 
consisted of cell retraction and rounding, and syncytium 
formation. Changes in EHV-2 infected F1M1 organ cultures 
consisted of rounding and shedding of ciliated and non-ciliated 
epithelial cells. A difference was observed in the two culture 
systems in regard to the time of appearance of peak virus titers 
and cytopathic changes. In cell cultures cytopathic changes 
preceeded peak virus titers by at least 24h whereas in the 
organ cultures the two parameters coincided. Thus infection 
patterns in cell and organ cultures exhibit significant 
variations, and by coupling studies in both culture systems with 
pathogenicity experiments in animals, much more useful 
information may be obtained.
Cell morphology changes caused by EHV-2 were investigated 
further by studying the kinetics of cytoskeletal and cytopathic 
changes (cell rounding and syncytium formation) in FPAM.
Results indicated that cytopathic changes or CPE were subsequent 
to changes in the organization of cellular microfilaments (MF) 
and microtubules (MT). It was suggested that these cytoskeletal 
changes were better than CPE when employed for early detection 
of infections by slowly cytopathic viruses such as EHV-2 and the 
cytomegaloviruses. Further studies on the mechanism of EHV-2 
induced disruption of MT and MF involving the use of metabolic
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inhibitors were indicated. Such investigation would be expected 
to provide answers to not only how CPE is produced by cytocidal 
viruses, but also how cell shape and intracellular transport of 
macromolecules might be controlled.
In the present study, infection of nasal and tracheal 
cultures by EHV-2 did not seem to exert a profound effect on 
ciliary activity per se, but the observed EHV-2 induced 
shedding of ciliated cells could impair the effectiveness of the 
clearance of microbes or particulate matter by the mucociliary 
defense mechanism.
In comparison with EHV-1, EHV-2 displayed slow growth and 
delayed cytopathology in both cell and organ cultures. It is 
noteworthy that in the cell cultures, EHV-2 attained slightly 
higher peak titers than EHV-1 whereas in organ cultures the 
reverse happened; EHV-1 was released to higher peak titers 
(10-fold or more) than EHV-2. It is possible that IF may be 
partly responsible for the low EHV-2 titers in the organ 
cultures whereas rapid multiplication and efficient release of 
EHV-1 may have accounted for high titers of the virus in these 
cultures. In the cell cultures a more efficient release on a 
per cell basis of EHV-2 may have occurred. In reference to 
cytopathology, EHV-1 affected the cell and organ cultures more 
severely causing extensive destruction of cell monolayers and 
nasal and tracheal epithelia.
In general, the cell culture results confirmed the findings 
of other investigators and the organ culture observations 
appeared to lend support to previous in vivo findings, as
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discussed in the preceeding chapters. Overall, the present 
results seem to indicate that EHV-2 is potentially pathogenic 
but less so than EHV-1, and that pathogenicity studies with 
organ and cell cultures can extend our knowledge of viral 
infections of the respiratory tract.
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